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Streptococcus pneumoniae (or pneumococcus) is a frequent colonizer of the 
nasopharynx and an important cause of infectious diseases, with a high rate of 
morbidity and mortality worldwide, particularly among young children, the elderly and 
the immunocompromised. Despite this high burden of morbidity and mortality, invasive 
pneumococcal disease is incidental. Nasopharyngeal colonization is the preferred 
lifestyle for the pneumococcus, its prevalence being particularly high among young 
children 
Colonization by more than one S. pneumoniae strain, or co-colonization, is frequent 
and is important for pneumococcal biology because it promotes intra-specific 
competition and evolution. Moreover, understanding co-colonization is critical to 
monitor the impact of pneumococcal conjugate vaccines (PCV) and the extent of 
serotype replacement by minor serotypes when vaccination targets the most abundant 
ones. Despite its relevance and the fact that it has been recognized for several 
decades, co-colonization remains poorly studied, mainly because high throughput 
methods of multi-type detection have been developed only recently. 
In this thesis we conducted five studies that aimed at understanding the dynamics of 
pneumococcal co-colonization and how it is affected by pneumococcal conjugate 
vaccines and by specific properties and mechanisms intrinsic to S. pneumoniae. 
In the first study we used a molecular-based strategy to detect co-colonization in 
nasopharyngeal samples from the pre- and vaccine eras, in order to evaluate the 
impact of the introduction of the seven-valent pneumococcal conjugate vaccine (PCV7) 
on pneumococcal co-colonization in Portuguese children. We showed that co-
colonization rates were significantly lower (p=0.004; Fisher’s exact test) among fully 
vaccinated children (8.0%) than among children from the pre-PCV7 era (17.3%) or 
unvaccinated children of the PCV7 era (18.3%). We showed also that in PCV7 
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vaccinated children there was an asymmetric distribution of non-vaccine types (NVT) 
found in single and co-colonization events and we have attributed this asymmetry to 
differences in the competitive abilities of serotypes. We proposed that some NVTs 
prevalent in the PCV7 era are more competitive than others, impairing their co-
existence in the same niche. The results obtained in this study may have important 
implications since a decrease in co-colonization events is expected to translate in 
decreased opportunities for horizontal gene transfer, hindering pneumococcal evolution 
events, and might represent a novel potential benefit of conjugate vaccines. 
The replacement of PCV7 by PCV13 (13-valent PCV) has raised the question on 
whether this vaccine would have a similar effect on co-colonization. To address this 
question, in the second study we used a similar approach to the one used in the study 
conducted in the PCV7 era. We showed lower co-colonization prevalence in PCV13 
fully vaccinated children, compared to children who had not received any PCV (20.6% 
vs. 29.3%), an observation that supports the results obtained in the first study. As 
before, we reported an asymmetric redistribution of NVTs in single and co-colonization 
events in the vaccinated group, which supported our hypothesis of different competitive 
abilities among NVT serotypes. Moreover, we showed that PCV13 serotypes are still 
highly prevalent in a population with no universal but very high vaccine coverage, 
mainly among non-vaccinated children. In vaccinated children PCV13 serotypes were 
found mainly as minor serotypes, while in the non-vaccinated group these serotypes 
were highly prevalent in single carriage events and were present in high relative 
abundance in most co-colonization events. Overall, the results obtained in this study 
regarding the impact of PCV13 on co-colonization corroborated the potential impact of 
PCVs on pneumococcal ecology by decreasing co-colonization events and, thus, 
decreasing opportunities for horizontal gene transfer. 
In the third study we used knowledge previously obtained through the use of highly 
sensitive molecular methods of detection of co-colonization to quantify the bias 
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associated with the use of colony morphology for detection of co-colonization, a 
convenient approach that has been the basis of most reports on co-colonization in 
surveillance studies that do not systematically look for co-colonization. Comparison of 
the serotype distribution of co-colonized samples detected through both methodologies 
revealed that detection based on colony morphology resulted in a 20% 
overrepresentation of serotypes that display very distinctive colony morphologies, such 
as serotype 3 and non-encapsulated pneumococci, which did not reflect the real 
epidemiology of these serotypes on the pneumococcal population.  
In the fourth and fifth studies we explored how co-colonization might be affected by 
specific properties and mechanisms intrinsic to S. pneumoniae biology.  
In the fourth study we determined the impact of pherotype-mediated competition (or 
competence stimulating peptide, CSP) on pneumococcal co-colonization using a 
collection of co-colonized samples containing two strains of different serotypes. CSP 
assignment of all pneumococci revealed that in 52.5% of the samples both strains were 
of the same pherotype, while in 47.5% co-colonizing strains were of a different 
pherotype. Comparison of the observed proportions of concordant and discordant 
pherotypes with the ones estimated (53.8% and 46.2%, respectively), revealed no 
significant differences. The results obtained in this study supported the hypothesis that 
there is a limited role of pherotype-mediated competition on co-colonization. 
In the fifth study we explored the impact of the blp (bacteriocin-like peptide) locus and 
bacteriocin secretion on co-colonization. We characterized the blp locus of a highly 
diverse collection of co-colonizing strains and determined their inhibitory activity 
through competition overlay assays. For comparison, we performed the same 
characterization in a collection of pneumococci isolated from single carriage events. 
We showed that co-colonizing pneumococci present high genetic diversity at the level 
of this locus and display several phenotypes of bacteriocin secretion and immunity. We 
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showed also that pneumococcal strains co-colonize individuals independently of the 
genetic content of their blp-locus and independently of their phenotypes of bacteriocin 
secretion, and that phenotypes of bacteriocin secretion are the same in strains isolated 
from single and co-colonization events. Overall, the results obtained in this study 
support the hypothesis that there is a limited role of the blp-locus and bacteriocin 
secretion on co-colonization. 
In conclusion, the results obtained in this thesis improved the scarce knowledge on 
pneumococcal co-colonization through the use of innovative methodologies and by 
addressing important questions such as the impact of PCVs and bacterial competition 




A bactéria Streptococcus pneumoniae (pneumococo) coloniza assintomatica e 
frequentemente a nasofaringe e é também uma importante causa de doença 
infecciosa, com elevadas taxas de mortalidade e morbilidade, sobretudo em crianças, 
idosos e indivíduos imuno-comprometidos. A colonização da nasofaringe é, no 
entanto, preferencial no ciclo de vida do pneumococo, sendo particularmente elevada 
em crianças até aos seis anos. 
A colonização da nasofaringe por mais do que uma estirpe de S. pneumoniae, ou co-
colonização, é frequente. O estudo da co-colonização é importante dada a sua 
relevância para a biologia do pneumococo, por promover interacções intra-específicas 
e, consequentemente, a evolução da espécie. Além disso, compreender a co-
colonização é fundamental para a monitorização do impacto das vacinas 
pneumocócicas conjugadas (PCV) e do grau de substituição de serótipos por serótipos 
minoritários, num cenário em que a vacina é dirigida contra os serótipos mais 
abundantes. Apesar de a co-colonização ser reconhecidamente importante e um 
fenómeno identificado há já várias décadas, continua pouco estudada, sobretudo 
devido ao facto de apenas recentemente terem sido desenvolvidos métodos 
adequados à sua detecção.  
No âmbito desta tese foram realizados cinco estudos com o objectivo de entender a 
dinâmica da co-colonização por pneumococos e qual o impacto das PCVs e de certas 
propriedades e mecanismos intrínsecos à biologia desta bactéria neste fenómeno. 
Com o objectivo de avaliar o impacto da introdução da vacina pneumocócica 
conjugada sete-valente (PCV7) na co-colonização por pneumococos em crianças 
portuguesas, realizámos o primeiro estudo, recorrendo a métodos moleculares para 
detectar co-colonização em amostras da nasofaringe de crianças obtidas antes e após 
a introdução da PCV7. Os resultados indicaram que crianças vacinadas com PCV7 
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completa apresentavam uma prevalência de co-colonização  significativamente inferior 
(8.0%) à de crianças não vacinadas no mesmo período (18.3%) ou no período pré-
vacinal (17.3%). Nas crianças vacinadas observou-se uma distribuição assimétrica dos 
serótipos não vacinais (NVT) nos eventos de co-colonização e colonização simples 
(i.e., colonização por uma só estirpe), assimetria essa que atribuímos a diferenças nas 
capacidades competitivas dos serótipos. Esta observação levou à proposta de que 
alguns NVT prevalentes na era vacinal são muito competitivos, impedindo a sua co-
existência com outros serótipos no mesmo nicho. Os resultados deste estudo poderão 
ter implicações relevantes dado que uma diminuição nos eventos de co-colonização 
poderá traduzir-se numa diminuição das oportunidades para a ocorrência de 
transferência horizontal de genes e, consequentemente, dos eventos de evolução, 
representando potencialmente um novo benefício das vacinas conjugadas. 
A substituição da PCV7 pela PCV13 (PCV treze-valente) levou-nos a questionar se 
esta vacina teria um efeito semelhante ao da PCV7 na co-colonização. Deste modo, 
no segundo estudo adoptámos uma abordagem semelhante à do estudo da era da 
PCV7. Demonstrámos que a prevalência de co-colonização em crianças com 
vacinação completa (20.6%) era inferior à de crianças não vacinadas do mesmo 
período (29.3%). Em concordância com o estudo anterior, observámos uma 
distribuição assimétrica de NVT em eventos de co-colonização e colonização simples, 
facto que suporta a hipótese previamente proposta de diferenças nas capacidades 
competitivas dos serótipos. Demonstrámos ainda que os serótipos incluídos na PCV13 
são ainda prevalentes na população. Nas crianças vacinadas os serótipos incluídos na 
PCV13 foram encontrados como um serótipo minoritário na maioria das ocorrências, 
enquanto que no grupo de não-vacinados estes serótipos eram muito prevalentes em 
eventos de colonização simples ou como serótipo maioritário em eventos de co-
colonização. Os resultados apresentados neste estudo relativos ao impacto da PCV13 
na co-colonização suportam a hipótese do que as PCVs podem alterar a ecologia do 
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pneumococo pela diminuição dos eventos de co-colonização e das oportunidades para 
transferência horizontal de genes. 
No terceiro estudo usámos informação obtida previamente através do uso de métodos 
moleculares na detecção de co-colonização para quantificar o viés associado à 
detecção de co-colonização com base na morfologia das colónias de pneumococos. 
Dada a sua conveniência, esta abordagem baseada na morfologia constitui a base da 
maioria dos dados reportados na literatura relativos à prevalência de co-colonização. A 
comparação da distribuição de serótipos em amostras co-colonizadas com detecção 
efectuada através de ambas as metodologias demonstrou que a detecção com base 
na morfologia das colónias aumenta em 20% a prevalência de serótipos que 
apresentam morfologias mais facilmente distinguíveis, como é o caso do serótipo 3 e 
dos pneumococos não-encapsulados, podendo alterar artificialmente a prevalência 
estimada destes serótipos na população. 
No quarto e quinto estudos, explorámos o impacto de propriedades e mecanismos 
intrínsecos à biologia do pneumococo na co-colonização. 
No quarto estudo avaliámos o impacto da competição mediada pelo ferótipo (ou 
péptido indutor da competência) na co-colonização, recorrendo a uma colecção de 
amostras co-colonizadas por duas estirpes de pneumococos. A determinação do 
ferótipo para todas as estirpes revelou que 52.5% das amostras continham estirpes 
com o mesmo ferótipo, enquanto que nas restantes as estirpes eram de ferótipos 
diferentes. A comparação das proporções de amostras com ferótipos concordantes 
(52.5%) e discordantes (47.5%) com as proporções estimadas (53.8% e 46.2%, 
respectivamente) não revelou diferenças significativas. Estes resultados sugerem que 
a competição mediada pelo ferótipo tem um impacto limitado na co-colonização. 
No quinto estudo explorámos o impacto do locus blp (bacteriocin-like peptide) e da 
secreção de bacteriocinas, i.e., produção de péptidos antimicrobianos pelas bactérias, 
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na co-colonização. Caracterizámos o locus de uma colecção muito diversa de 
pneumococos identificados em eventos de co-colonização e determinámos a sua 
capacidade inibitória através de ensaios de competição em meio sólido. Utilizámos 
como controlo uma colecção de pneumococos isolados de eventos de colonização 
simples. Demonstrámos que os pneumococos a co-colonizar apresentam uma elevada 
diversidade genética ao nível do locus blp e exibem diferentes fenótipos de secreção 
de bacteriocinas e de imunidade. Adicionalmente, reportámos que os pneumococos 
co-colonizam um hospedeiro independentemente dos fenótipos de secreção de 
bacteriocinas e que os mesmos não são diferentes em estirpes de co-colonização e de 
colonização simples. Os resultados obtidos neste estudo sugerem que o impacto do 
locus blp e da secreção de bacteriocinas na co-colonização é limitado. 
Em suma, os resultados apresentados nesta tese aumentaram o conhecimento sobre 
a co-colonização por pneumococos através do uso de metodologias inovadoras e da 
resposta a questões importantes, tais como o impacto das PCV e dos mecanismos de 





The purpose of this thesis was to gain insights on the dynamics of pneumococcal co-
colonization and how it is affected by pneumococcal conjugate vaccines and by 
specific properties and mechanisms intrinsic to S. pneumoniae biology. 
Chapter I is a general introduction where important aspects of S. pneumoniae 
epidemiology and biology, relevant for the scope of the thesis, are presented. Among 
these, are pneumococcal epidemiology, effects of anti-pneumococcal vaccination, 
importance of co-colonization, methods for detection of co-colonization, and bacterial 
properties and competition mechanisms that might impact on co-colonization.  
Chapter II describes the assessment of co-colonization in a collection of 
nasopharyngeal samples obtained from vaccinated and non-vaccinated children, 
encompassing the availability of PCV7 in Portugal, aiming at determining the impact of 
this vaccine on co-colonization. The analysis includes the combination of two sensitive 
molecular methods for detection of co-colonization and comparison of co-colonization 
patterns among children sampled in the pre-PCV7 era, and vaccinated and non-
vaccinated children sampled in the PCV7 era. 
Chapter III describes a study conducted to evaluate the impact of PCV13 on co-
colonization. Samples obtained from PCV13 vaccinated and non-vaccinated children 
were analyzed with a capsular microarray to detect co-colonization and the two groups 
were compared regarding co-colonization patterns. 
Chapter IV describes a study conducted to assess the bias in the serotype distribution 
of pneumococci associated with co-colonization detection based on colony 
morphology. The strategy used was based on the comparison of the serotype 
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distribution of co-colonized samples detected by molecular methods and by colony 
morphology. 
Chapter V describes the impact of pherotype-mediated fratricide on co-colonization. 
The analysis included pherotype assignment of a co-colonized collection of 
nasopharyngeal samples and estimation of the proportion of samples co-colonized with 
strains of the same or of a different pherotype for comparison with the observed 
proportions. 
Chapter VI describes the impact of the blp (bacteriocin-like peptide) locus and 
bacteriocin secretion on pneumococcal co-colonization. The analyses included genetic 
characterization of the blp locus of co-colonizing strains and assessment of the 
phenotype of bacteriocin secretion through overlay assays. Comparison with a control 
collection of strains isolated from single carriage events was also performed. 
Chapter VII presents general conclusions of the studies conducted in this thesis and 
enumerates several questions that remain unanswered and could be the focus of future 
research. 
Chapters II, IV and V are reproductions of the following publications and can be read 
independently: 
Chapter II - Valente, C., J. Hinds, F. Pinto, S. D. Brugger, K. A. Gould, K. 
Mühlemann, H. de Lencastre, R. Sá-Leão. 2012. Decrease in pneumococcal co-
colonization following vaccination with the seven-valent pneumococcal conjugate 
vaccine. PLoS ONE; 7(1):e30235. doi: 10.1371/journal.pone.0030235. 
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Chapter IV - Valente, C., H. de Lencastre, R. Sá-Leão. 2013. Selection of distinctive 
colony morphologies for detection of multiple carriage of Streptococcus pneumoniae. 
Pediatr. Infect. Dis. J.; 32(6):703-4. doi: 10.1097/INF.0b013e31828692be. 
Chapter V - Valente, C., H. de Lencastre, R. Sá-Leão. 2012. Pherotypes of co-
colonizing pneumococci among Portuguese children. Microbe Drug Resist; 18(6):550-
4. doi: 10.1089/mdr.2011.0228. 
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Streptococcus pneumoniae, on the vanguard of scientific 
discoveries  
Streptococcus pneumoniae, or pneumococcus, is an important human pathogen, 
continuing to kill thousands of people and being still “the captain of the men of death”, 
as William Osler called it in 1918 (Osler, 1901). 
The first reports about “elongated diplococci” in infected lungs are from Edwin Klebs 
and date back to 1875. It was only in 1881, however, that this bacterium was first 
isolated and its pathogenic potential was established, by both Louis Pasteur and 
George Sternberg (reviewed in (Watson et al., 1993)).  
Several designations were attributed to the pneumococcus along the years (reviewed 
in (Watson et al., 1993)) taking into consideration the shape and type of disease 
caused by the bacteria but, in 1974, the name Streptococcus pneumoniae was adopted 
based on its morphology in chains when grown in liquid medium (Bergey, 1974). 
Due to its important role as a human pathogen, S. pneumoniae is one of the most well 
studied bacteria. For this reason, it is not surprising that it has been center stage to 
important medical and scientific discoveries.  In the field of medicine, the 
pneumococcus was used in the development of Gram’s stain that allowed the 
distinction between Gram positive and Gram negative pathogenic bacteria (reviewed in 
(Watson et al., 1993)), the discovery of the ability of polysaccharides to induce antibody 
production and their use as antigens in vaccines (Avery, 1917; Heidelberger & Avery, 
1923),  and the confirmation of the therapeutic efficacy of penicillin (Tillett et al., 1944). 
In science, S. pneumoniae was the leading character in the discovery of the 
“Transforming Principle” and the mechanism of bacterial gene transfer (Griffith, 1928), 
in the identification of DNA as the genetic material (Avery et al., 1944), in the discovery 
of the protective role of the capsule against host phagocytic cells (Felton et al., 1955), 
and in the description of the first bacterial quorum-sensing mechanism (Tomasz, 1965), 
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all of which have contributed to even greater discoveries and, as of today, are still 
being used in the most various fields and applications. 
Over 130 years have passed since the discovery of the pneumococcus and science 
and medicine are still far from winning the battle against this highly successful 
pathogen. Recent estimates on the number of serious cases of pneumococcal disease 
reach over 14 million, from which over 0.8 million cases result in the death of children 
below five years of age (O'Brien et al., 2009) .  
 
Streptococcus pneumoniae 
S. pneumoniae is a Gram positive bacterium with the form of an elongated coccus 
(lancet-shaped). It varies between 0.5 and 1.5 µm in diameter and can be found 
isolated in single cells, in the form of diplococci, and in longer chains. Pneumococci are 
facultative anaerobic, display α-hemolytic activity when grown on blood-supplemented 
plates and are typically optochin susceptible and soluble in bile salts. It is a fastidious 
organism, its growth being favored in media containing blood, at 37ºC, and in a CO2-
supplemented atmosphere (CDC, 2012; Sneath, 1986).  
The genome of S. pneumoniae is a covalently closed circular DNA molecule of ~2M 
base pairs, varying, in size and content, from strain to strain. It contains over 1500 
genes that are essential for cell viability and a variable number of genes essential for 
virulence or to maintain a non-invasive phenotype (Bijlsma et al., 2007; Hava & Camilli, 
2002; Lanie et al., 2007; Obert et al., 2006; Orihuela et al., 2004). S. pneumoniae 
possesses a highly plastic genome, with several recombination hotspots, which 
constitutes an evolutive advantage and makes it one of the most well adapted 
pathogens. The genomic variability of S. pneumoniae strains has been demonstrated 
(Chewapreecha et al., 2014; Dagerhamn et al., 2008; Hanage et al., 2006; Hiller et al., 
Introduction 
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2007; Obert et al., 2006). In fact, analysis of 17 sequenced genomes showed that only 
46% of the homologous gene clusters were common between strains (Hiller et al., 
2007).  
Due to all the diversity in pneumococcal population and to the need to classify and 
cluster pneumococcal strains in the context of epidemiological studies, a gold-standard 
fingerprinting method, MLST (multi-locus sequence typing) is generally used as a 
typing method, in which a sequence type (ST) is assigned to a strain based on the 
combination of the allelic variants of seven housekeeping genes – aroE, gdh, gki, recP, 
spi, xpt, and ddl (Enright & Spratt, 1998) (http://www.mlst.net/). 
One of most distinctive characteristics of the pneumococcus is its polysaccharide 
capsule, which led Avery to name it “the sugar-coated microbe” (Bardossi, 1988). This 
capsule has antigenic properties which can be used as an identification method, 
through the Quellung reaction, by the use of specific antisera (Sorensen, 1993). The 
capsule is the main pneumococcal virulence factor and has several distinct functions 
that will be discussed later in this chapter. Based on different antigenic properties 
conferred by biochemical and structural differences of the polysaccharide capsule, over 
95 capsular types, or serotypes, have been described up to now (Calix & Nahm, 2010; 
Jin et al., 2009; Oliver et al., 2013; Park et al., 2007; Park et al., 2015). 
 
Epidemiology of S. pneumoniae 
 Pneumococcal colonization 
S. pneumoniae is a frequent inhabitant of the human nasopharynx, co-existing 
commensally with the human host. Colonization can occur soon after birth and remains 
high in the first three years of life, decreasing until the age of ten and remaining low 
during adulthood (Bogaert et al., 2004a). Virtually every child is colonized by the 
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pneumococcus at least once in life and each serotype can colonize for several weeks 
or months, being then replaced by another serotype or reacquired (Gray et al., 1980; 
Sá-Leão et al., 2008).  
Carriage is usually asymptomatic and its duration varies according to the serotype of 
the strain, the age of the child and the immunological status, as it allows the individual 
to acquire B cell mediated immunity against the carried serotype. A low mucosal 
immunity will result in persistent and repeated colonization events, while a stronger 
local response will accelerate clearance and prevent re-colonization (Bogaert et al., 
2004a; Weinberger et al., 2008).  
Asymptomatic carriers constitute a reservoir of pneumococci in the community and are 
important vehicles of transmission, which can occur via direct contact between 
individuals, by aerosols, or by contact with contaminated abiotic surfaces (Musher, 
2003; Walsh & Camilli, 2011).  
Risk factors for pneumococcal carriage include young age (up to 2 years of age), 
regular contact with young children, crowding (as occurs in day care centers, prisons, 
hospitals, and military camps), previous respiratory disease, both infectious and 
chronic, and cigarette smoking (Abdullahi et al., 2012; Almeida et al., 2014; Bogaert et 
al., 2004a; Gray et al., 1980; Labout et al., 2008). 
Several studies have been conducted worldwide on the subject of pneumococcal 
carriage (Adegbola et al., 2014; Cohen et al., 2012; Daana et al., 2015; Vestrheim et 
al., 2010) (Nunes et al., submitted), most of them focused on young children attending 
day care centers, as this is the age group where colonization is more frequent and  
crowding is high in day care centers, favoring transmission (Bogaert et al., 2004a; Sá-
Leão et al., 2008). These studies have shown that the carriage rates and the 
distribution of the carried serotypes vary across geographical locations, reaching 
values as low as 20% (Frederiksen & Henrichsen, 1988) and as high as 80% 
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(Vestrheim et al., 2010). In Portugal, studies conducted in the Lisbon area report a 
pneumococcal carriage rate of ~64% in 2010 (Nunes et al., submitted). 
 Pneumococcal disease 
From the nasopharynx pneumococci can spread to other body sites to cause a wide 
range of diseases that vary in prevalence and severity. The most common forms of 
disease are mild infections such as acute otitis media (AOM) and sinusitis. The 
nasopharynx is connected to the middle ear via the Eustachian tube which, if clogged, 
can trap bacteria and cause a middle ear infection. Despite being a mild infection, AOM 
has a high socio-economic impact as it is the leading bacterial infection in children in 
high income countries and the primary reason for antibiotic prescription (Hau et al., 
2013). In fact, by the age of 3 years, over 80% of the children are estimated to have an 
AOM episode and over 40% to have recurrent episodes (Vergison et al., 2010). 
Overall, the serotypes more frequently associated with AOM are serotype 3, 6A, 6B, 
9V, 11A, 14, 19A, 19F and 23F, although this may vary with geographical location and 
vaccine coverage (discussed below in this chapter) (Rodgers et al., 2009). 
The pneumococcus can also be responsible for more severe infections, such as 
pneumonia (non-invasive disease), bacteremia and meningitis (invasive disease). 
Pneumonia is the non-invasive pneumococcal disease with highest burden in adults. It 
has high incidence rates and high mortality risk, especially in the elderly, and is the 
most common infectious source for invasive pneumococcal disease (Drijkoningen & 
Rohde, 2013).  
The incidence of invasive pneumococcal disease (IPD) in any population depends on 
several factors, such as geographic location, season of the year, serotype prevalence, 
age, co-morbidities, and vaccine coverage (Drijkoningen & Rohde, 2013; Hausdorff et 
al., 2005) (Figure 1). The highest reported incidence of IPD is in adults over 65 years of 
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age, children younger than 2 years of age, and those with certain underlying conditions 
that compromise the immune system, such as HIV infection and chronic diseases.  
The World Health Organization estimated the occurrence of 14.5 million global cases of 
serious illness in children less than 5 years old (O'Brien et al., 2009). According to the 
USA Active Bacterial Core surveillance (ABCs) database of the Emerging Infections 
Program Network, in 2013, the incidence of invasive pneumococcal disease in 
individuals >65 years of age was 30.5 cases per 100,000 population and, in infants <1 








The serotype prevalence in disease also varies with age, vaccine coverage and type of 
disease. Serotypes 4, 6B, 9V, 14, 18C, 19F and 23F were the most prevalent in 
pediatric invasive disease in the USA before the introduction of the seven-valent 
pneumococcal conjugate vaccine (PCV7) (Hausdorff et al., 2005), while serotype 19A 
emerged after PCV7 introduction (Richter et al., 2009). Serotypes 1, 4 and 14 have 
been associated with bacteremia (Hausdorff et al., 2000). Serotype 1 has also been 
associated with pneumonia, together with serotype 3 (Hausdorff et al., 2005). 
Figure 1. Incidence rate of invasive pneumococcal disease in children under 5 years 
old. (per 100,000 individuals). 2009. WHO website, adapted (http://www.who.int/).  
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In Portugal, a study has shown that serotypes 1, 7F and 19A accounted for 61% of 
pediatric invasive pneumococcal disease cases between 2006 and 2008 (Aguiar et al., 
2010). 
From the information provided above it is clear that, although there are over 95 
serotypes described, only a few are responsible for causing disease. Several studies 
have aimed at establishing differences in invasive potential among serotypes 
(Brueggemann et al., 2003; Brueggemann et al., 2004; Greenberg et al.; Sá-Leão et 
al., 2011; Sleeman et al., 2006). These studies had different designs and were 
conducted in different geographical locations but the overall results were similar, as 
most reported a high invasive disease potential for serotypes 1, 3, 4, 5, 7F, 9V, 14, and 
18C. The study conducted in Portugal identified the same serotypes as having a high 
invasive potential, among others, while serotypes 6A, 6B, 11A, 15B/C, 16F, 19F, and 
23F, among others, to be mostly associated with colonization (Sá-Leão et al., 2011). 
More importantly, this study has shown that different genetic lineages of the same 
serotype have different invasive potential, as is the case of serotypes 3, 6A, 6B, 19A, 
19F, and 23F, among others. 
 
Non-susceptibility to antimicrobial agents 
Non-susceptibility of S. pneumoniae to commonly used antibiotics has been reported 
worldwide (CDC; ECDC, 2013) and has increased dramatically since the description of 
the first clinical isolate resistant to an antimicrobial agent (penicillin) in 1967 (Hansman 
et al., 1971).  
The distribution of non-susceptible isolates seems to be associated with the capsular 
type, the geographical area and antibiotic consumption levels of each area, and with 
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pneumococcal conjugate vaccine coverage (Dagan & Klugman, 2008; Goossens, 
2009; Hausdorff et al., 2005; Riedel et al., 2007).  
In general, high rates of non-susceptibility are observed in countries with high antibiotic 
consumption, such as Southern and Eastern European countries, whilst low non-
susceptibility rates are observed in countries with low antibiotic consumption, such as 
Northern European countries (Goossens, 2009; Riedel et al., 2007). Accordingly, 
strains isolated from carriage tend to be more frequently non-susceptible to 
antimicrobial agents than strains isolated from disease episodes (Hausdorff et al., 
2005).  
The latest report from the European Center for Disease Control and Prevention 
(ECDC) showed that, in 2013, the percentage of isolates non-susceptible to penicillin 
causing invasive disease ranged between < 1.1% (the Netherlands) and 40.0% 
(Cyprus), while for macrolides non-susceptibility rates ranged between 1.5% (Latvia) 
and 38.1% (Romania) (ECDC, 2013). In the USA, in the same year, the percentages of 
penicillin and macrolide non-susceptible isolates were 4.7% and 28.5%, respectively 
(CDC). 
In Portugal, data from carriage isolates from 2010 showed percentages of non-
susceptibility to penicillin and macrolides of 19.6% and 25.2%, respectively. The same 
study showed that in that period, non-susceptibility to those antimicrobial agents was 
associated mainly with serotypes 6C, 15A, 19A, 19F, and non-encapsulated isolates 
(Nunes et al., submitted). 
A study focused on isolates causing invasive disease in Portugal, from 2006-2008, 
showed that the rates of non-susceptibility to penicillin and macrolides were 18.7% and 
22.9%, respectively. This study has also shown that non-susceptibility to those 
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antimicrobial agents was associated mainly with serotypes 19A, 14, 19F, 6C and 23F 
(Aguiar et al., 2010).  
Anti-pneumococcal vaccination 
Being S. pneumoniae “the captain of the men of death” (Osler, 1901), it is not 
surprising that several attempts have been made throughout history to prevent 
pneumococcal disease through vaccination. 
Although not effective, the first attempt was the use of killed whole bacterial cells to 
immunize mineworkers, in 1911, to prevent death by pneumonia (Wright et al., 1914). 
The demonstration of the efficacy of pneumococcal vaccines was a long process, 
mainly due to flawed study designs and serious adverse effects of the vaccines. 
Although some clinical trials were undertaken, the discovery of antibiotics and their 
efficacy against pneumococcal disease put this process on hold, until Robert Austrian 
proved the efficacy of pneumococcal polysaccharide vaccines and, as a consequence,  
the 14-valent polysaccharide vaccine was licensed (Austrian et al., 1976). In 1983 this 
vaccine was extended to 23 serotypes and licensed, being still in the market with the 
commercial name of Pneumovax© 23 (PPV23). PPV23 is immunogenic for serotypes 
1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 
23F, and 33F when administered in adults, the elderly and children older than 2 years 
of age, as in younger children, who have an underdeveloped immune system, it fails to 
induce an adequate immune response (Bogaert et al., 2004b; Douglas et al., 1983).  
In 2000, the first pneumococcal conjugate vaccine (PCV7) was licensed and introduced 
in the National Immunization Plan in the USA, with the commercial name of Prevnar©, 
and protecting against the seven serotypes more prevalent in pneumococcal disease in 
children under 6 years of age: 4, 6B, 9V, 14, 18C, 19F, and 23F (CDC, 2000). The 
polysaccharide of these serotypes was conjugated to a protein carrier, CRM197, 
resulting in a better immunogenicity in young children.  
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Two additional conjugate vaccines have been developed in more recent years: a 10- 
and 13-valent vaccine, in 2009 and 2010, respectively (Synflorix© and Prevnar©13, 
respectively). Synflorix© (PCV10) includes the 7 serotypes present in PCV7 and 3 
additional serotypes - 1, 5 and 7F – conjugated to Haemophilus influenza protein D as 
the carrier protein. Prevenar©13 (PCV13) replaced PCV7 in 2010 and includes six 
additional serotypes, conjugated to the same carrier protein, CRM197: 1, 3, 5, 6A, 7F, 
and 19A.  
In Portugal, PCV13 was introduced in the National Immunization Plan for children born 
after January 2015 on a scheme of two doses followed by a booster dose. 
Nevertheless, PCVs have been available in the market since June 2001 (PCV7), April 
2009 (PCV10) and January 2010 (PCV13) and their use in young children has been 
recommended by the Pediatric Portuguese Society. Estimates on PCV7 coverage in 
2009 reached 62%, while PCV10 coverage was estimated to be 13% in the same year 
(data from the National Statistics Institute (INE) and IMS).  
Effects of pneumococcal vaccination 
The introduction of PCV7 has led to several changes in pneumococcal epidemiology 
and population structure. These changes are more or less significant according to the 
vaccine coverage and geographic location and included: (i) decrease in IPD in 
vaccinated children, (ii) decrease in IPD in non-vaccinated children and in adults, as a 
reflex of the herd-immunity effect, (iii) increase in the incidence of IPD caused by non-
vaccine serotypes, and (iv) replacement of vaccine types by non-vaccine types in 
carriage. The USA, a country with immediate massive PCV7 use, is a good example of 
all these changes. A 77% decrease in IPD cases in vaccinated children was reported 
four years after vaccine introduction (CDC, 2008) and later a 45% decrease in IPD in 
all age groups was observed, accompanied by a 94% reduction of vaccine types 
(Pilishvili et al., 2010). Additionally, the incidence of invasive disease cases attributed 
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to non-vaccine types also increased in the first years of vaccination, particularly due to 
serotype 19A (Hicks et al., 2007).  
In Europe, the same effects were observed but with some variability among countries, 
depending on vaccine coverage. Decrease in IPD incidences varied between 28% and 
68% and serotype replacement was also observed, with non-vaccine serotypes 1, 19A, 
3, 6A, and 7F being the ones with higher incidence in IPD after widespread use of 
PCV7 (reviewed in (Isaacman et al., 2010)). 
In Portugal, the same scenario was observed. The incidence of IPD cases associated 
with PCV7 serotypes was reduced from 56% (before PCV7 introduction) to 17% by 
2006-2008, in children aged up to 17 years of age (Aguiar et al., 2010). Carriage of 
PCV7 serotypes also decreased, while the prevalence of non-PCV7 serotypes 
increased, maintaining the overall prevalence of carriage in the population (Sá-Leão et 
al., 2009) (Nunes et al., submitted). 
Since serotypes included in PCV7 are frequently resistant to antimicrobial agents, 
introduction of PCV7 vaccination was predicted to have an impact on the levels of 
antimicrobial resistance worldwide (Dagan & Klugman, 2008; Kyaw et al., 2006). This 
decrease was, in fact, observed following the first years of vaccination but was rapidly 
compensated by the emergence of drug-resistant non-PCV7 serotypes (Mera et al., 
2009). In Portugal, antimicrobial resistance rates were maintained, despite the 
widespread use of PCV7 (Simões et al., 2011) (Nunes et al., submitted). 
PCV10 and PCV13 have similar effects on the population as the ones described for 
PCV7, with reports on the impact these vaccines becoming more frequent (Hammitt et 
al., 2014; Jokinen et al., 2015; Moore et al., 2015; Waight et al., 2015). In the USA a 
study reported a decrease of 93% in IPD cases attributable to PCV13-only serotypes, 
in children under 5 years old, and a decrease of 58-72% in adults, depending on age, 
for the same serotypes (Moore et al., 2015). In the UK, the reduction of PCV13-only 
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serotypes IPD cases was of 69% for all ages (Waight et al., 2015). However, both 
studies reported an increase in IPD cases associated with non-PCV13 serotypes, 
particularly in children under 5 years old, evidence of the serotype replacement 
expected to occur.  
Despite the serotype replacement that has been observed and that is attributable to the 
fact that current vaccines only target a limited number of serotypes, the strategy of 
targeting the most prevalent serotypes in IPD has been highly successful. However, 
the adaptability of the pneumococcal population to these human interventions has been 
a driving force for the development of the ideal vaccine. This vaccine would be a 
conserved, universally present surface protein, capable of eliciting a good immune 
response in all age groups. No such protein has been described so far but several 
initiatives are ongoing, using surface proteins, combinations of proteins or an whole cell 
approach to find a vaccine that could ultimately overcome the limitations of currently 
used conjugate vaccines (reviewed in (Feldman & Anderson, 2014)).  
 
Pneumococcal co-colonization  
Biological significance  
The preferential niche of the pneumococcus is the nasopharynx, a polymicrobial 
environment where the pneumococcus is forced to interact with other microorganisms 
of the same or different species. Simultaneous colonization by more than one 
pneumococcal strain, or co-colonization, is frequent and is of high clinical, 
epidemiological and ecological relevance (O'Brien & Nohynek, 2003; Shak et al., 
2013).  
It has been shown that colonizing pneumococcal strains can interfere both negatively 
and positively with colonization by other strains (Dawid et al., 2007; Lipsitch et al., 
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2000; Marks et al., 2012b). Marks et al. (Marks et al., 2012b) have shown in a mouse 
model that strains with poor colonization efficiency have their efficiency improved when 
in co-colonization with a highly efficient strain that is already established. This 
improvement was independent of genetic exchange between strains. On the other 
hand, Lipsitch et al. (Lipsitch et al., 2000) have shown, also in a mouse model, that 
carriage of an established strain can inhibit acquisition of a second strain in a strain- 
and density-dependent manner. The inhibition was observed through a reduced 
colonization probability and/or through reduced cell counts in the colonized animals. 
Additionally, some molecular mechanisms have been shown to contribute to inter-strain 
interactions, namely bacteriocin production and competence-mediated fratricide, which 
will be discussed later in this chapter (Dawid et al., 2007; Guiral et al., 2005). 
Co-colonization is a requirement for horizontal gene transfer between pneumococci 
through homologous recombination, a mechanism important for evolution in this 
species (Coffey et al., 1991; Feil et al., 2000; Smith et al., 1993; Spratt et al., 2001). 
Several studies reported the occurrence of genetic exchange in biofilm models (Carrolo 
et al., 2014; Marks et al., 2012b; Wei & Havarstein, 2012) and also in in vivo models 
(Marks et al., 2012b). Additionally, Hiller et al. (Hiller et al., 2010) have shown the 
occurrence of genetic rearrangements in vivo that generated genetic diversity during a 
pediatric chronic infection. Several population genetic studies have also shown the 
occurrence of genetic recombination, including capsule switching events (Croucher et 
al., 2011; Donkor et al., 2011). Donkor et al. (Donkor et al., 2011) have used an MLST 
approach to characterize pediatric colonization strains and they found evidence of 
extensive recombination among those strains, which they have related to the high 
prevalence of co-colonization in the population.  
Besides the evolutionary implications, DNA exchange between co-colonizing strains 
can have important clinical and epidemiological consequences, not only because it has 
been shown in animal models of disease that minor genetic differences can induce 
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significant changes in the virulence of a strain (Hiller et al., 2011), but also because this 
genetic exchange has played a role in the development and evolution of antibiotic 
resistance (Dowson et al., 1989). The occurrence of capsule switching events is also of 
importance as it can have an impact on the virulence of strains and, in the context 
vaccine effectiveness, can result in the emergence of vaccine escape recombinants 
(Brueggemann et al., 2007). In the same context, understanding co-colonization is 
critical to monitor the extent of serotype replacement by minor serotypes when 
vaccination targets the most abundant ones (Lipsitch, 1999; Lipsitch, 2001; Spratt & 
Greenwood, 2000). 
Another important clinical implication is the increasing evidence that co-colonization 
might be associated with higher colonization densities. Brugger et al (Brugger et al., 
2010) showed that colonization density was significantly higher in nasopharyngeal 
swabs containing multiple pneumococcal strains, compared to swabs with a single 
strain. Accordingly, Margolis et al (Margolis et al., 2010) have shown, in a neonatal rat 
model, that sequential colonization with two pneumococcal strains results in increased 
colonization densities to allow the co-existence of the pulsed and the established 
strains. This is of great importance due to the increasing interest in using 
nasopharyngeal colonization density as a diagnostic tool for pneumonia (Albrich et al., 
2012). Moreover, a study that assessed co-colonization events in samples from healthy 
children and children with acute respiratory infection has shown that the latter group 
was significantly more co-colonized (Dhoubhadel et al., 2014). 
 
Epidemiology 
The epidemiology of co-colonization is generally unknown. There are several 
surveillance studies that report colonization by more than one strain in the same host, 
but the majority of these studies are not comparable since they have used different 
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methods of detection and most have not systematically looked at co-colonization (for a 
review see (O'Brien & Nohynek, 2003)).  
Studies that used the same detection method (serotyping of multiple colonies) suggest 
that co-colonization prevalence is highly variable across geographical settings, ranging 
between 3% and 36% (Gratten et al., 1989; Hansman & Morris, 1988; Ussery et al., 
1996). Also, there is some evidence that co-colonization prevalence in a given setting 
might be associated with the carriage levels in that setting, i.e., settings with higher 
carriage prevalence will have higher co-colonization levels (Brugger et al., 2010; 
Kandasamy et al., 2015; Turner et al., 2011). 
There is little data on the effect of vaccination on co-colonization. Brugger et al. 
(Brugger et al., 2010) have used a highly sensitive method to detect co-colonization in 
nasopharyngeal samples collected between 2004 and 2009, spanning PCV7 
introduction in Switzerland. They concluded that the rate of co-colonization was similar 
before and after the introduction of PCV7 and that it was associated with younger age, 
as children younger than 2 years of age were significantly more co-colonized. This 
study has also shown that co-colonization rates are independent of the vaccination 
status of the child, which is in disagreement with the results obtained in Portugal, 
where it was shown that, in the vaccine era, children with four PCV7 doses were 
significantly less co-colonized than non-vaccinated children (see chapter II).  
 
The quest for the perfect detection method 
The first reports on co-colonization were obtained by successive intraperitoneal saliva 
injections in mice to detect multiple serotypes (Gundel et al. (Gundel M, 1933), 
reviewed in (Shak et al., 2013)). Using this strategy, Gundel et al. reported a 73% rate 
of co-colonization. Although impractical, this methodology was the basis for the 
standard approach of using enrichment steps of the nasopharyngeal sample, followed 
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by serotyping of several colonies, to detect co-colonization.  The latter strategy was 
used for several years and constitutes the basis of most reports on co-colonization 
(Barker et al., 1989; Gratten et al., 1989; Hansman & Morris, 1988; Huebner et al., 
2000; Ussery et al., 1996). Despite being the most straightforward approach for 
detection of co-colonization, serotyping of multiple colonies has proved to be of little 
value due to its low sensitivity to detect less abundant serotypes in a nasopharyngeal 
sample. Huebner at al. (Huebner et al., 2000) have shown that, to have a 95% chance 
of detecting a serotype present in a sample in a relative abundance of 1%, one would 
need to serotype 299 colonies. This is highly demanding in feasibility and cost.  
For the reasons mentioned above, several alternative serotyping methods have been 
developed, taking into consideration the ability to detect co-colonization. The criteria to 
define a good detection method rely on the ability of that method to (i) detect minor 
serotypes with high specificity, (ii) detect serotypes directly from the nasopharyngeal 
specimen, (iii) detect all known serotypes, (iv) distinguish pneumococci from closely 
related species, (v) be quantitative, and (vi) be affordable (Satzke et al., 2012; Satzke 
et al., 2014). 
These methods can be divided into phenotypic and genotypic and some are variants of 
the same technology (Table I).  
Most phenotypic methods are either bead-based (Park et al., 2000; Sheppard et al., 
2011; Whaley et al., 2010) or blot-based immunoassays (Bogaert et al., 2004c; 
Bronsdon et al., 2004). The blot-based methods have the advantage of being cost-
effective because they use highly diluted typing sera but they are technically 
demanding and can be of difficult interpretation due to cross-reactions. The bead-
based methods are technically demanding and of difficult implementation, as they 
require very expensive equipment and extensive optimization.  
Introduction 
19 
Turner et al. (Turner et al., 2011) have also developed a phenotypic method based on 
latex agglutination. This method uses an enrichment step of the nasopharyngeal 
specimen according to the WHO recommendations and resuspension of the primary 
selective growth on a saline solution to be tested against all available typing sera, 
allowing the detection of virtually all capsular types or groups. The authors were able to 
detect minor serotypes that corresponded to down to 25% of the total pneumococcal 
population. 
The genotypic methods include PCR-based methods, including real-time PCR, and 
microarray-based methods. Their main advantage is their higher sensitivity, when 
compared to phenotypic methods, which enables the detection minor serotypes 
present in a very low abundance that could be below the culturable limit. 
Several multiplex-PCR systems were developed that are able to detect co-colonization, 
although all of them require a previous enrichment of the nasopharyngeal specimen 
(Morais et al., 2007; Rivera-Olivero et al., 2009; Yu et al., 2011). These methods have 
the limitation of having low discriminative power in closely-related capsular types, of not 
being quantitative and the fact that most of them target a limited number of capsular 
types. They present high sensitivity and are of straightforward implementation and 
execution. 
Real-time PCR based methods have also been developed (Azzari et al., 2010; Pimenta 
et al., 2012). These methods are extremely sensitive but are limited by the low 
discriminative power in closely-related capsular types and by the optimization 
difficulties for multiplexing. Azzari et al. (Azzari et al., 2010) have shown, however, the 
main advantage of this approach, by demonstrating its ability to detect co-colonization 
directly from the nasopharyngeal sample with a four times higher sensitivity than 

































The main drawback of both conventional and real-time PCR based methods is the 
possible occurrence of false positive results associated with the fact that these 
methods use as target fragments of capsular genes that can potentially be present in 
other inhabitants of the nasopharynx, such as closely related Streptococcus spp.  
(Carvalho Mda et al., 2013). 
Brugger et al. (Brugger et al., 2009) have developed a PCR-based method which takes 
advantage of a highly conserved and specific genetic region within the pneumococcal 
species, adjacent to the pneumolysin gene (ply), which encodes for a major virulence 
factor and is highly specific for pneumococcus. This variable noncoding region adjacent 
to the ply gene (plyNCR) is amplified by PCR and the PCR product is then digested for 
restriction fragment length polymorphisms (RFLP). The restriction is performed with 
four enzymes used independently and the samples are analyzed by capillary 
electrophoresis for exact size assessment of the digestion fragments. When the sum of 
the restriction fragments exceeds the size of the undigested product (c.a. 1400 bp), 
there is evidence that more than one pneumococcal strain exist in the sample. This 
method has high throughput but requires expensive equipment and reagents and a 
fairly high level of technical expertise, as interpretation of results can be misguided by 
incomplete digestion or presence of closely-related Streptococcus spp. The greatest 
disadvantage of this method is related to the fact that it does not discriminate the 
serotypes of the co-colonizing strains. For this reason, it has to be coupled with another 
genotypic method that has this ability. 
Genotypic methods based on comparative genomic hybridization (CGH) have also 
been developed (Hinds et al., 2010; Tomita et al., 2011; Turner et al., 2011; Wang et 
al., 2007). However, to our best knowledge, only the microarray developed by Hinds et 
al. (Hinds et al., 2010; Turner et al., 2011) has the ability to detect all capsular types 
described up to now.  In this method each capsular gene is targeted by ten 60-mer 
oligonucleotide reporters resulting in a very robust method for the assignment of 
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capsular types. As detection is based on fluorescently labeled oligomers, this 
microarray is able to quantify the relative abundance of each capsular type in the total 
of pneumococcal DNA present in the samples. Despite being very sensitive, this 
method is not suitable for detection directly from the nasopharyngeal specimen, 
although optimization is ongoing (Satzke et al., 2012). The main drawback of this 
method is, however, the requirement of very expensive reagents and equipment and 
high level of technical expertise. 
Due to the existence of all these different approaches and to the increasing relevance 
attributed to co-colonization in vaccine surveillance studies, an initiative was 
undertaken under the scope of the PneuCarriage project in which 20 methods were 
compared for their ability to detect co-colonization with a good cost/benefit ratio. This 
assessment is being done by using a reference collection of spiked samples mixed with 
real samples, in which methods with the best performance in detecting minor serotypes 
with good positive predictive value will be selected for a second round that consists in 
the analysis of 200 field samples (Satzke et al., 2012). First reports announced that 
four methods were selected for the second stage of evaluation: the microarray 
developed by Hinds et al. (Hinds et al., 2010; Turner et al., 2011), the latex 
agglutination method developed by Turner et al. (Turner et al., 2011), the plyNCR-
RFLP coupled with multiplex PCR, developed by Brugger et al. (Brugger et al., 2009), 




Co-colonization has been known to occur for many years, although the factors 
determining its occurrence and the interactions that occur between strains inside the 
host only recently have begun to be addressed.  
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Several theoretical models have been used to predict which are the determinants of co-
colonization and strain interactions, all of them considering the capsular type as the 
decisive factor to distinguish between strains (Auranen et al., 2009; Cobey & Lipsitch, 
2012; Zhang et al., 2004). These studies have resulted in the formulation of important 
premises about between-strain competition and carriage of multiple serotypes: co-
colonization does not seem to accelerate clearance (Auranen et al., 2009), established 
colonization with one serotype reduces risk of acquisition of a second serotype 
(Auranen et al., 2009), serotype-specific immunity stabilizes competition, and acquired 
immunity to non-capsular antigens reduces fitness differences between strains, being 
relevant for competition (Cobey & Lipsitch, 2012; Zhang et al., 2004). Notwithstanding, 
these theoretical principles have not been sufficiently addressed experimentally.  
Experimental and epidemiological data on this subject is scarce and the bacterial 
factors that might affect this phenomenon are generally unknown. In the following 
sections information regarding some bacterial factors that might have an impact on co-
colonization and that are relevant in the context of this thesis will be presented. 
 
The contributions of the capsule and genetic background to 
(co)colonization 
The ability of a strain to colonize an individual is intrinsically related to its ability to resist 
clearance. With the objective of determining the invasive potential of different 
serotypes, Sleeman et al. (Sleeman et al., 2006) have shown that less invasive 
serotypes are carried for longer periods. Most studies that have addressed which 
factors contribute to the a success of a strain in colonization have focused on the role 
of the capsule, as it is the main target of the immune system in the clearance process 
and was the first factor shown to be important for S. pneumoniae virulence. The 
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capsule prevents clearance and aggregation, affects colonization and adherence, helps 
the pneumococcus to survive in the lungs and spread to the bloodstream, and 
contributes to antibiotic tolerance. Pneumococci regulate the amount of capsular 
material produced during colonization and invasion. Transparent capsules (thin) are 
favored during initial colonization stages to promote adherence to host epithelial cells, 
while opaque capsules (thick) are favored during invasion to resist complement-
mediated opsonophagocytosis (Fernebro et al., 2004; Lysenko et al., 2005; Mac & 
Kraus, 1950; Morona et al., 2004; Nelson et al., 2007; Weiser et al., 1994).  
Weinberger et al. (Weinberger et al., 2009) have shown that the structure of the 
capsular polysaccharide can predict serotype prevalence. These authors and others 
have shown that serotypes with capsule structures with more carbon in their 
polysaccharide repeat unit required more energy for capsule production, displaying 
thinner capsules. Therefore, these serotypes were less resistant to phagocytosis and 
clearance, which correlated with their lower prevalence (Hathaway et al., 2012; 
Weinberger et al., 2009). Other capsule-related properties have been studied to explain 
the influence of the capsular type on pneumococcal colonization, such as the surface 
charge. Li et al. (Li et al., 2013) have shown that the surface charge correlates with the 
prevalence of serotypes in colonization, as more negatively charged capsular types are 
more prevalent than less charged capsular type and capsules more negatively charged 
were shown to repel host immune cells that contribute to clearance, such as 
neutrophils and macrophages.  
Several epidemiological studies have shown that there is high variability in strains of 
the same serotype (Brueggemann et al., 2003; Hanage et al., 2005; Sá-Leão et al., 
2011; Sandgren et al., 2004) and this observation is supported by the increasing 
available genomic data (Chewapreecha et al., 2014; Hakenbeck et al., 2001; Hiller et 
al., 2007). This genetic variation is associated with the capsular type to some extent 
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(http://www.mlst.net/). For this reason, the differences observed between capsular 
types might be partially related to the genetic background of the strains. 
Moreover, several capsule-independent factors have been shown to interfere with 
complement-mediated immunity (reviewed in (Jarva et al., 2003)), highlighting the 
importance of the genetic background of the bacteria to avoid clearance and, in this 
way, promote colonization. Yuste et al. (Yuste et al., 2009) have shown that loss of the 
pneumococcal surface protein C (PspC) affected differently pneumococcal strains 
regarding complement activation by C3 deposition, and this effect was dependent on 
the strain background. Pneumococcal histidine triad proteins have also been shown to 
promote complement evasion on a background-dependent manner (Melin et al., 2010). 
Hyams et al. (Hyams et al., 2011) also demonstrated that genetically distinct S. 
pneumoniae strains with the same capsular serotype vary in their sensitivity to 
complement mediated immunity, re-enforcing the importance of the genetic 
background to colonization. 
Another important aspect that promotes colonization is the ability of strains to produce 
and survive in a biofilm, as there is growing evidence that this lifestyle is important for 
colonization (Hoa et al., 2009; Kania et al., 2008; Marks et al., 2012a; Psaltis et al., 
2007; Sanclement et al., 2005). This ability is not solely dependent on the serotype of 
the strains (Blanchette-Cain et al., 2013) and several non-capsular bacterial factors 
have been shown to be important for biofilm formation (Blanchette-Cain et al., 2013; 
Sanchez et al., 2010; Vidal et al., 2013). On the other hand, although the type of 
capsule does not seem to be important for biofilm formation, the modulation of the 
capsular expression was shown to be critical, with less encapsulated variants being 
important for the initial stages of attachment (Domenech et al., 2009). 
Overall, both the capsule and the genetic background are important factors to promote 
colonization and, hence, they must impact on carriage of multiple strains by the same 
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host, even if indirectly. The contribution of these bacterial properties has never been 
addressed experimentally in the context of co-colonization. The experiments performed 
by Lipsitch et al. (Lipsitch et al., 2000), previously mentioned, have shown that 
competition in vivo occurs in a strain dependent manner but the contribution of the 
capsule or the genetic diversity of the strains has not been sufficiently addressed. Very 
recently, Trzcinski et al. (Trzcinski et al., 2015) have shown in co-infection experiments 
in a mouse model, using clinical strains and isogenic variants of the same capsular 
types, that there was a stable hierarchy of capsular types colonizing the animals in 
different conditions. Moreover, the authors were able to correlate this hierarchy with 
serotype specific fitness predicted by capsule-dependent properties, such as capsule 
synthesis metabolic cost and surface charge (Li et al., 2013; Weinberger et al., 2009). 
These results suggest a significant role of the capsule on strains competitive abilities 
and fitness when interacting with strains of other serotypes. 
 
Chemical war I - competence-mediated fratricide  
The pneumococcus is naturally transformable, which means it can acquire external 
DNA and incorporate it into its own chromosome. This ability of the pneumococcus was 
first shown by Griffith in 1928 (Griffith, 1928) but the first insights on pneumococcal 
competence were provided only in the 1960s by Tomasz and Hotchkiss, first by 
describing that competence induction is dependent on cell density (Tomasz & 
Hotchkiss, 1964) and then by showing that it is controlled by a hormone-like cell 
product, later identified as the competence stimulating peptide (CSP) (Tomasz, 1965). 
Induction of competence is tightly regulated by the comABCDE genes, that encode for 
the signaling peptide CSP (comC), a dedicated ABC transporter (comAB) and a two 
component regulatory system (comDE) composed by a cognate histidine kinase 
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receptor (comD) and a response regulator (comE) (Havarstein et al., 1995a; Havarstein 
et al., 1996; Havarstein, 1998).  
CSP is synthesized inside the cell as a 24-aa pre-peptide that is cleaved upon 
secretion by the dedicated proteolytic ABC-transporter (Havarstein et al., 1995b), being 
secreted as a 17-aa peptide (Havarstein et al., 1995a). Accumulation of CSP in the 
medium stimulates the ComDE two component sytem (Pestova et al., 1996). The 
ComD receptor autophosphorylates upon binding to CSP and transphosphorylates the 
response regulator ComE (Havarstein et al., 1996). ComE activates transcription of the 
comABCDE genes, comX, which encodes the sigma factor that controls activation of 
late competence genes (Lee & Morrison, 1999), and comM, that encodes a membrane 
immunity protein expressed on the surface of competent cells only (Havarstein et al., 
2006).  
There are up to 124 genes that are regulated by competence (Dagkessamanskaia et 
al., 2004; Peterson et al., 2004), among which are the cibABC, encoding for a two 
peptide bacteriocin (cibAB) and an immunity protein (cibC), lytA, the major autolysin, 
and cbpD, an autolytic amidase (Guiral et al., 2005). The CibAB has been shown to be 
indispensible for the lysis of non-competent cells through a mechanism that requires 
contact between competent and non-competent cells and also the presence of 
hydrolases (LytA, LytC and CbpD), as CibAB by itself is not enough to induce bacterial 
lysis of non-competent cells. This CibAB-mediated lysis of non-competent cells 
promoted by competent ones was shown to be important to explain lysis in solid media 
and was designated by allolysis (Guiral et al., 2005). Added to the protection from 
CibAB by CibC, competent cells are also protected from their over-expressed 
hydrolases CbpD, LytA and LytC by the immunity protein ComM, which was shown to 
protect competent cells from their own lysins in liquid culture (Havarstein et al., 2006). 
Contrary to CibC that protects competent cells exclusively from the action of CibAB, the 
specificity of ComM is not known yet. It has not been established yet whether this protein 
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protects cells specifically against the action of CbpD, or if the immunity is directed 
against LytA and/or LytC (Figure 2). 
These competence-mediated lysis mechanisms target non-competent cells, regardless 
of whether they are isogenic - as would be the case in a monoculture - or non-isogenic 
to the competent ones - in the case of a co-culture of different strains - and is generally 
designated by fratricide. In either case, lysis requires the co-existence of competent 












The pheromone CSP is prone to allelic variation (Havarstein et al., 1995a; Whatmore et 
al., 1999) and this can contribute to the occurrence of fratricide when strains of different 
pherotypes come across each other, as the ComD receptor only recognizes its cognate 
CSP type. Two dominant allelic variants have been identified in the pneumococcal 
Figure 2. Mechanisms of competence-mediated fratricide. In a population of mixed 
pherotypes, the competence-race is won by the pherotype that accumulates higher 
concentration of its own CSP in the medium. Sensing of CSP induces competence in the 
population that expresses that cognate ComD receptor, resulting in the cascade of events 
described in the text. Adapted from (Guiral et al., 2005; Johnsborg et al., 2008; Johnsborg 
& Havarstein, 2009). 
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population – CSP1 and CSP2 (Pozzi et al., 1996; Ramirez et al., 1997; Whatmore et 
al., 1999). 
The impact of pherotype on within-host competition has not been fully addressed. If on 
one hand it has been shown that the type of CSP restricts competence within 
pherotypes, which is important for fratricide (Guiral et al., 2005; Johnsborg et al., 2008), 
on the other hand, to what extent these mechanisms are important for the co-existence 
of different pneumococci in the same host has not been clarified yet. A number of 
studies that used biofilm models to simulate dual-strain carriage have shown that 
fratricide occurs in those conditions and that it is important for gene transfer between 
strains (Carrolo et al., 2014; Marks et al., 2012b; Wei & Havarstein, 2012). Marks et al. 
(Marks et al., 2012b) have shown that competence genes are up-regulated in 
conditions that mimic the nasopharyngeal environment (lower temperature, limited 
nutrient availability and interaction with epithelial cells) and also that competence is 
induced during dual-strain carriage in vivo. None of these studies has, however, 
addressed the question of whether the co-existence of strains of different pherotypes 
could be impaired by this induction of competence. 
Using an epidemiological approach, Vestrheim et al. (Vestrheim et al., 2011) have 
looked at pairs of co-colonizing strains to evaluate the impact of pherotype on the co-
existence of pneumococci in the nasopharynx. The authors showed that pneumococcal 
pherotypes often co-exist in the nasopharynx and suggested that the impact of 
competence induced fratricide on competition is limited. However, this study used co-
colonized samples identified on the basis of colony morphology, a method shown to 
underestimate co-colonization events and to introduce a bias in the serotype 
distribution of co-colonizing strains (for a reference see Chapter IV). 
In line with the observation of Vestrheim et al., Carrolo et al. (Carrolo et al., 2014) have 
shown that, within biofilms, intra-pherotype fratricide prevails over inter-pherotype 
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fratricide, probably due to the spatial organization of strains of different pherotypes 
within the biofilm. This hypothesis is supported by the observation that physical contact 
between competent and non-competent cells might be needed for fratricide to occur 
(Havarstein et al., 2006). 
Despite this, at what extent competence-mediated fratricide impacts on pneumococcal 
co-existence in the nasopharynx remains to be understood. 
 
Chemical war II - bacteriocin secretion 
Microbes in general are equipped with a large assortment of defense-attack systems: 
broad-spectrum classical antibiotics, metabolic by-products, lytic agents, several types 
of protein exotoxins and bacteriocins, which are loosely defined as biologically active 
proteins/peptides with a bactericidal activity (reviewed in (Riley & Wertz, 2002; Tagg et 
al., 1976)). Among all existing microbial defense-attack systems, bacteriocins seem to 
be the preferential weapon as these toxins have been found in all Phyla of Bacteria and 
have been described to be produced by some Archaea members (Klaenhammer, 1988; 
Torreblanca et al., 1994). The key difference between bacteriocins and traditional 
antibiotics is that, contrary to antibiotics, bacteriocins have a relatively narrow killing 
spectrum and are only toxic to bacteria closely related to the producing strain (Eijsink et 
al., 2002). It is, in fact, this property that is on the basis of the increasing interest of 
bacteriocins as “designer drugs” to combat bacterial infections, in an attempt to 
decrease the pressure for the selection of antibiotic resistance and the collateral killing 
of commensal species (reviewed in (Cotter et al., 2012)). 
In general, bacteriocins are short hydrophobic and/or amphipatic peptides, ribosomally 
synthesized as an inactive preptide with an N-terminal leader sequence and a C-
terminal propetide. The leader sequence targets bacteriocins to a dedicated transporter 
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and keeps bacteriocins in an inactive form until they are secreted (Nissen-Meyer et al., 
2009). There are several types of bacteriocins that are divided in four classes: i) 
lantibiotics (modified bacteriocins), ii) unmodified peptides, iii) large proteins, and iv) 
cyclic peptides (Heng & Tagg, 2006). The bacteriocins discussed in the context of this 
thesis belong to the second class. 
All bacteriocin producing strains are immune to their own product through a mechanism 
not well understood yet. For most bacteriocins the immunity gene(s) is located either in 
the same operon as the bacteriocin gene or in close vicinity.  
Genomic analysis of eleven sequenced S. pneumoniae strains has identified nine 
putative bacteriocin-like gene clusters, one cluster of class I and the remaining eight of 
class II. These clusters were shown to vary in presence and content among those 
strains (Majchrzykiewicz, 2011). Of these, only two class II gene clusters have been 
shown to induce antimicrobial activity: the blp (bacteriocin-like peptide) and cib 
(competence-induced bacteriocins) loci. The role of the cib locus was described 
previously in this chapter. In addition, very recently Bogaardt et al. (Bogaardt et al., 
2015) have described a cassette encoding a circular bacteriocin that was present in 
one third of a diverse collection of over 300 sequenced pneumococci. These authors 
have shown that this cassette had a genetic organization similar to other circular 
bacteriocin cassettes well characterized in other species. However, no experimental 
data on the antimicrobial activity of this cassette was presented yet. 
 
The blp - bacteriocins   
In S. pneumoniae, the blp locus encodes a number of bacteriocins that have been 
implicated in intraspecific competition in a murine model of colonization (Dawid et al., 
2007). These bacteriocins are characterized by the presence of a conserved N-terminal 
leader peptide, followed by a typical double-glycine motif where the prepeptide is 
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cleaved upon secretion (Bogaardt et al., 2015; Dawid et al., 2007; de Saizieu et al., 
2000; Son et al., 2011).  
The blp locus (Figure 3) encodes a signalling peptide, BlpC, a two component system, 
BlpRH, constituted by an histidine kinase cognate receptor (BlpH) and a response 
regulator (BlpR), an ABC transporter, BlpAB, and the bacteriocin and immunity region 
(BIR), which contains bacteriocin peptides and their cognate immunity proteins, 
typically co-transcribed (Dawid et al., 2007; Reichmann & Hakenbeck, 2000; Son et al., 
2011). In addition, downstream to the BIR, the locus contains also conserved proteins 
thought to be involved in immunity (blpYZ and SPO547) (Dawid et al., 2007; de Saizieu 











Bacteriocin secretion is tightly regulated by the two component system. Activation of 
the system occurs upon binding of the signalling peptide BlpC to its cognate BlpH 
receptor, after secretion of BlpC by the dedicated ABC transporter BlpAB (Dawid et al., 
Figure 3. blp locus and model of locus activation. BlpC is secreted by the ABC 
transporter BlpAB. At high cell-density, BlpC accumulates extracellularly and is sensed by its 
cognate receptor BlpH, which in turn activates the response regulator BlpR. BlpR up-
regulates the transcription of the entire locus at the sites marked by the arrows above the 
locus, including the BIR. Bacteriocin peptides are also secreted by BlpAB and immunity 
proteins are expressed at cell surface. Adapted from (Son et al., 2011). 
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2007; Reichmann & Hakenbeck, 2000). BlpC is secreted at basal levels but once a 
critical threshold is reached, BlpR is phosphorilated, which has been shown to result in 
the upregulation of the entire locus, including blpC and the BIR. Bacteriocin peptides 
are also secreted by the ABC transporter BlpAB and immunity proteins are expressed 
at cell membrane (de Saizieu et al., 2000).  
Little is known of other regulation mechanisms of blp bacteriocin secretion other than 
the cognate two component system BlpRH. It was shown that the ComDE regulatory 
system is able to upregulate, likely indirectly, some of the blp genes (blpZYA, involved 
in the production of transport and immunity proteins) (Peterson et al., 2004). Also, the 
conserved protease HtrA has been shown to control activation of the locus and 
bacteriocin secretion by limiting BlpC processing and secretion. In this way, locus 
activation is restricted to high cell density, preventing unnecessary and energetically 
costly bacteriocin secretion at low cell density (Dawid et al., 2009; Kochan & Dawid, 
2013).  
The blp locus is characterized by high diversity. The blpA gene, encoding the ABC 
transporter, contributes for this variability, as it can correspond to a single open reading 
frame (ORF) or it can be divided in smaller ORFs due to the presence of frameshift 
mutations or deletions. Son et al. (Son et al., 2011)  have described an interruption of 
the ORF by a widely conserved 4 bp repeat insertion that renders strains with an 
otherwise intact blp locus unable to secrete both the peptide pheromone and the 
bacteriocin peptides. Despite their defective transport system, these strains are able to 
recognize exogenous peptides, resulting in the expression of immunity proteins without 
the cost of peptide secretion, this being the reason that led the authors to designate 
these strains as “cheaters”. Cheater strains are at risk upon encounter with a strain that 
secretes a BlpC peptide different from the one they can sense. In the same study, the 
authors refer to the presence of other loss of function mutations and deletions in the 
blpA gene, although no additional details are provided. Also in the context of blpA 
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disruption, Kjos et al. (Kjos et al., 2015) have shown, very recently, a correlation 
between the com and blp systems, demonstrating that a strain with a disrupted blpA 
(D39) was able to activate its blp locus using comAB as a transport system. Whether or 
not this is a general behaviour in pneumococci remains to be assessed, but, if this is 
the case, than there would be no cheater strains in the population, with all the 
ecological implications associated with this observation. 
Another source of variability of the blp locus is the peptide pheromone, blpC, for which 
at least 5 allelic variants have been described: blpCT4, blpCR6, blpC6A, blpCP164, and 
blpCP155, the first four being dominant in the population (de Saizieu et al., 2000; 
Pinchas et al., 2015; Reichmann & Hakenbeck, 2000; Son et al., 2011). Despite the 
correspondence typically found between signalling peptide and receptor in this type of 
regulatory systems, the allelic variation in the pheromone receptor, blpH, is higher, due 
to the existence of naturally occurring chimeras for this gene. Pinchas et al. (Pinchas et 
al., 2015) have found that blpH6A has three sub-alleles, whose gene products share 
98% sequence identity: blpH6A.1, blpH6A.2 and blpH6A.3. These authors have shown that 
the BlpH variants have different specificities to the BlpC pheromone: BlpHP164 and 
BlpHR6 respond only to their cognate BlpC pheromone, while BlpH6A.1 and BlpH6A.2, 
respond to both BlpCT4 and BlpC6A, although the sensitivity of the receptor to the non-
cognate pheromone is lower. BlpH6A.3 is a BlpHP164/6A chimera and responds to both 
BlpCP164 and BlpC6A, although with higher sensitivity to the non-cognate pheromone 
BlpCP164. 
The bacteriocin immunity region (BIR), enclosing genes that code for bacteriocins and 
their cognate immunity proteins, typically co-transcribed, is also highly variable, both in 
size and content. At least sixteen putative bacteriocin peptides have been described so 
far, some of which present allelic variability (Bogaardt et al., 2015; Son et al., 2011). 
This variability may in inhibition upon the encounter of two strains, even if they can 
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sense the same signalling peptide, as cells will only express immunity proteins against 
the bacteriocin peptides that they secrete.  
The mode of action of these bacteriocins is not elucidated yet in S. pneumoniae, but 
the most plausible mode of action is through pore formation on the citoplasmic 
membrane of susceptible cells, as described for most class II bacteriocins (Hechard & 
Sahl, 2002; Majchrzykiewicz, 2011).  
The putative immunity proteins present in this region are membrane proteins but their 
function and mode of action has not been experimentally demonstrated yet. Some 
cassettes contain also a CAAX amino-terminal protease (Bogaardt et al., 2015; Dawid 
et al., 2007; de Saizieu et al., 2000). CAAX proteases have been proposed to be 
involved in immunity against bacteriocins but they remain poorly studied in prokaryotes 
(Kjos et al., 2010; Pei & Grishin, 2001). For this reason little is known about the 
mechanism of protection of these proteins. They are putative membrane-bound 
metalloproteases thought to recognize and protect, most likely by proteolytic cleavage, 
a common receptor to the bacteriocin they protect from (Lux et al., 2007; 
Majchrzykiewicz, 2011; Nes & Hole, 2000). The blp locus contains two additional CAAX 
proteases at the end of the cassette, downstream of the BIR, BlpY and BlpZ. BlpY has 
been shown to be essential for immunity and bacteriocin activity (Lux et al., 2007). 
The importance of blp bacteriocins has been demonstrated in a murine model of 
colonization. Dawid et al.(Dawid et al., 2007) have used wild type and bacteriocin-
deleted mutants in dual colonization experiments and have observed that the 
production of bacteriocins by the wild type strains was able to inhibit the growth of the 
deleted mutants. These results showed that the locus is active in vivo and is able to 
play a role in the polymicrobial environment of the nasopharynx. How extensive this 




Aim of the thesis 
Although pneumococcal co-colonization has been known for several decades, it 
remains poorly studied. Its detection is important for monitoring vaccine effectiveness 
since it allows the distinction between unmasking and serotyping replacement 
phenomena. Also, colonization with multiple serotypes is thought to be the driving force 
for competition and evolution in the species, either by competition for nutrients or by 
promoting gene exchange between strains.  
The work developed under the scope of this thesis aimed at (i) determining the 
prevalence of co-colonization among Portuguese children and evaluating the impact of 
the introduction of pneumococcal conjugate vaccines on its dynamics; (ii) identifying 
significant positive or negative associations between pneumococcal strains; and (iii) 
exploring the molecular mechanisms that could underlie significant associations, 
focusing on bacterial-related properties such as the capsule, the genetic background, 
competence mediated-fratricide, and bacteriocin secretion. 
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Summary 
Understanding the epidemiology of pneumococcal co-colonization is important for monitoring 
vaccine effectiveness and the occurrence of horizontal gene transfer between pneumococcal 
strains. In this study we aimed to evaluate the impact of the seven-valent pneumococcal 
conjugate vaccine (PCV7) on pneumococcal co-colonization among Portuguese children. 
Nasopharyngeal samples from children up to 6 years old yielding a pneumococcal culture 
were clustered into three groups: pre-vaccine era (n=173), unvaccinated children of the 
vaccine era (n=169), and fully vaccinated children (4 doses; n=150). Co-colonization, 
serotype identification, and relative serotype abundance were detected by analysis of DNA 
of the total bacterial growth of the primary culture plate using the plyNCR-RFLP method and 
a molecular serotyping microarray-based strategy. The plyNCR-RFLP method detected an 
overall co-colonization rate of 20.1%. Microarray analysis confirmed the plyNCR-RFLP 
results. Vaccination status was the only factor found to be significantly associated with co-
colonization: co-colonization rates were significantly lower (p=0.004; Fisher’s exact test) 
among fully vaccinated children (8.0%) than among children from the pre-PCV7 era (17.3%) 
or unvaccinated children of the PCV7 era (18.3%). In the PCV7 era there were significantly 
less non-vaccine type (NVT) co-colonization events than would be expected based on the 
NVT distribution observed in the pre-PCV7 era (p=0.024). In conclusion, vaccination with 
PCV7 resulted in a lower co-colonization rate due to an asymmetric distribution between 
NVTs found in single and co-colonized samples. We propose that some NVTs prevalent in 
the PCV7 era are more competitive than others, hampering their co-existence in the same 
niche. This result may have important implications since a decrease in co-colonization 
events is expected to translate in decreased opportunities for horizontal gene transfer, 
hindering pneumococcal evolution events such as acquisition of antibiotic resistance 
determinants or capsular switch. This might represent a novel potential benefit of conjugate 
vaccines. 
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Introduction 
Streptococcus pneumoniae (the pneumococcus) remains a main cause of morbidity and 
mortality worldwide (O'Brien et al., 2009). Its ecological niche is the human nasopharynx. 
Colonization by pneumococcus can occur soon after birth and remains high in the first years 
of life (Bogaert et al., 2004). Virtually every child is colonized by pneumococcus at some 
stage in life and each serotype can colonize for several weeks being then replaced by 
another serotype or reacquired (Gray et al., 1980; Sá-Leão et al., 2008).  
Although poorly studied, it has been known for decades that simultaneous carriage of 
multiple pneumococci (or co-colonization) can occur (Griffith, 1928; Hodges et al., 1946). 
Co-colonization is an important event for pneumococcal evolution as it represents an 
opportunity for horizontal gene transfer, the main mechanism of evolution in this species 
(Barnes et al., 1995; Spratt et al., 2001).  
Studies on co-colonization have been hampered by the lack of suitable detection methods. 
The limited reports available have found co-colonization rates in the range of 5-30% 
(Brugger et al., 2009; Gray et al., 1980; Hare et al., 2008; Montgomery et al., 1990; O'Brien 
& Nohynek, 2003; Rivera-Olivero et al., 2009; Sá-Leão et al., 2002). However, most studies 
have relied on serotyping individual colonies isolated from culture. This approach has low 
sensitivity, is expensive and time-consuming and is biased to detect only the most abundant 
serotypes (Hare et al., 2008; Huebner et al., 2000).  
In recent years, with the introduction of multivalent pneumococcal conjugate vaccines, there 
has been a renewed interest in the study of co-colonization since it is important to 
understand serotype changes among carriers following vaccination, for instance, to 
distinguish increased acquisition from unmasking phenomena (Lipsitch, 1999). 
Simultaneously, novel approaches for detection of co-colonization have been proposed 
(Bronsdon et al., 2004; Brugger et al., 2009; da Gloria Carvalho et al., 2010; Rivera-Olivero 
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et al., 2009; Turner et al., 2011). In particular, Brugger et. al. have developed, the plyNCR-
RFLP method, based on the restriction pattern of a highly conserved DNA region within the 
pneumococcal species (Brugger et al., 2009). Additionally, Hinds et al. developed a 
molecular serotyping microarray based on genomic DNA hybridization that is able to detect 
and quantify all serotypes described to date (Hinds et al., 2010). 
In Portugal, the seven-valent pneumococcal conjugate vaccine (PCV7) became 
commercially available in June 2001 and, though the vaccine is not included in the National 
Immunization Program, it has been widely prescribed as the Portuguese Society of 
Pediatricians issued recommendation for PCV use among all young children. These included 
a catch up schedule. Rates of PCV coverage increased gradually since 2001. Estimates 
from Pfizer based on annual sales and considering 3.5 doses per newborn are as follows 
from 2001 to 2007: 17%, 32%, 56%, 65%, 63%, 75%, and 79%, respectively. In studies 
conducted by us, by 2006-2007, c.a. 70% of children (aged up to 6 years old) had received 
at least one PCV7 dose  (Simões et al., 2011). Major serotype shifts have occurred since 
2001 both in disease and colonization (Aguiar et al., 2008; Sá-Leão et al., 2009). Although 
colonization rates have remained stable (Aguiar et al., 2008; Sá-Leão et al., 2009), the effect 
of vaccination on co-colonization has remained unknown. 
In this study, using a combination of the plyNCR-RFLP and the molecular serotyping 
microarray methods, we aimed to gain insights on the prevalence of co-colonization and 
evaluate potential changes that might have occurred following vaccination with PCV7 in 
Portugal. 
 
Materials and methods 
Study design. Nasopharyngeal (NP) swabs collected from healthy children attending day-
care centers in Oeiras, Portugal, were retrospectively selected (Mato et al., 2005; Sá-Leão et 
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al., 2009). In each year, samples were collected in the winter months of January to March. 
Samples were selected according to the following criteria: (i) swabs were obtained from 
children aged 18-71 months; (ii) children had not received antibiotic within the month 
preceding sampling; and (iii) swabs yielded a pneumococcal positive culture upon direct 
plating within four hours of collection as described below. 
The samples were clustered in three groups matched for age and gender: group I included 
samples from the pre-vaccine era (n=173, collected in 2001); group II included samples 
collected in the vaccine era from unvaccinated children (n=169, collected in 2006-2007); and 
group III included samples collected in the vaccine era from fully vaccinated children (i.e., 4 
doses, n=150, collected in 2006-2007) (Supplementary Table). This study was nested in a 
previous one aimed to study the impact of PCV7 on colonization (Sá-Leão et al., 2009). 
Approval for the initial study was obtained from the Ministry of Education and directors of 
day-care centers. Signed informed consent was obtained from the parents or guardians of 
participating children. Samples and questionnaires were attributed a number and all 
information was treated anonymously. 
Isolation of pneumococci and sample preservation. NP samples were collected by 
pediatric nurses using mini-tip calcium alginate sterile swabs and inoculated directly within 4 
hours in a primary selective plate of 5% blood trypticase soy agar containing gentamicin (5 
mg/liter) to select for S. pneumoniae. Plates were incubated overnight at 37°C under 
anaerobic conditions, with an optochin disk. On the following day, presumptive 
pneumococcal colonies exhibiting different morphologies were picked (one colony per 
morphology) and subcultured. The remaining bacterial lawn was collected and frozen at -
80ºC in 1ml Mueller-Hinton broth containing 30% glycerol. On the third day, cultures derived 
from the isolated colonies were also frozen. Swabs from 2001 were discarded after plating; 
swabs from 2006 and 2007 were stored frozen.  
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PCR serotyping. Pure cultures were serotyped by PCR, as described previously (Pai et al., 
2006), using primers and conditions available at 
http://www.cdc.gov/ncidod/biotech/strep/pcr.htm. Strains that could not be typed by PCR 
were serotyped by the Quellung reaction using commercially available pneumococcal 
antisera (Statens Serum Institute, Copenhagen, Denmark).  
DNA isolation.  Total DNA was isolated from 200µl of the primary selective culture frozen 
stock using the High Pure PCR Template Preparation Kit (Roche Applied Science) according 
to the manufacturer’s instructions.  
plyNCR-RFLP. Detection of co-colonization was done as previously described (Brugger et 
al., 2009). Briefly, the noncoding region between the pneumolysin gene and the preceding 
hypothetical protein gene was amplified by PCR. The product was separately digested with 
up to four restriction enzymes: AflIII, ApoI, DdeI, and MseI. A sample was assumed to 
contain more than one strain whenever the sum of the size of the digestion fragments was 
higher than the size of the undigested PCR product.  
Molecular serotyping microarray. The BµG@S SP-CPSv1.4.0 microarray designed for S. 
pneumoniae molecular serotyping was used following standard protocols previously 
described (Brugger et al., 2010). Microarray data was statistically analyzed using a Bayesian 
hierarchical model to determine the serotype, or combination of serotypes, present in the 
sample and assign their relative abundance (Newton et al., 2011). In the interpretation of co-
colonization results, a serotype was classified as dominant if its relative abundance in the 
sample was ≥70%.  
Statistical analysis. Pair-wise associations between co-colonization and vaccination status, 
time period, age, gender and day-care center were measured. Statistical significance was 
accessed through Fisher exact tests. A Kolmogorov-Smirnov test was applied to compare 
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age distribution between multiple and single carriers. Associations were considered 
significant if p<0.05.  
Multivariate logistic regression models were used to detect associations with co-colonization, 
using vaccination status, time period, age, gender and day-care center as independent 
variables. As day-care center was a categorical variable with more than two categories, 14 
dummy variables (binary variables for all but one day-care centre) were constructed and 
used. 
Models were adjusted with all independent variables simultaneously and through backward 
and forward stepwise variable selection methods (which produced the same final models). 
Models were adjusted to subsets of data including only vaccine period individuals, or 
excluding vaccinated individuals. Although only 73 of 492 samples were positive for co-
colonization (as detailed in the results’ section) all 492 samples were used in the multiple 
logistic regression enabling the analyses of all variables under study. Indeed, according to 
Peduzzi et al. (Peduzzi et al., 1996), the size of our sample allows models with up to 7-8 
predictor variables. Furthermore, according to the later work of Vittinghoff and McCulloch 
(Vittinghoff & McCulloch, 2007), this number of predictors can safely be double if the aim of 
the analysis is to detect associations in observational data and not making predictions; or if 
the high number of predictors is necessary to control possible confounding variables. Our 
study fitted both conditions.  
Permutation analysis was done to test if serotypes were found in co-colonized carriers at 
frequencies different than expected by chance. For each time period, serotype identifications 
were randomly allocated to children (including not colonized) 2000 times. Serotype 
frequencies were maintained. The p-values obtained for all serotypes were corrected for 
multiple testing by controlling the False Discovery Rate below 0.05 (Benjamini & Hochberg, 
1995). 
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Analyses were performed in SPSS 17.0 and in Matlab 7.7. 
 
Results 
Co-colonization detected by colony morphology and by plyNCR-RFLP. Of the 492 
nasopharyngeal samples studied, two colonies with distinct morphologies were identified in 
the primary selective agar plate of 32 samples. Among these, two serotypes were isolated in 
17 samples; the remaining samples yielded a single serotype. Thus, the co-colonization rate 
detected by this method was 3.5%. The plyNCR-RFLP method detected pneumococcal co-
colonization in 20.1% of the 492 samples (n=99), a significantly higher proportion than the 
one found with the former approach (p<0.001, Ҳ2 test).  
Confirmation of co-colonization by molecular serotyping microarray. A total of 165 
samples were blindly tested using the microarray: the 99 samples in which pneumococcal 
co-colonization was detected by the plyNCR-RFLP, and 66 samples for which there was no 
evidence of co-colonization. Microarray results were in agreement with those generated by 
the plyNCR-RFLP method. 
In addition to identifying the serotypes present in samples, the microarray was also able to 
detect the presence of non-encapsulated pneumococci and/or closely related Streptococcus 
spp., collectively called non-typeables (NT). These were detected in 40 samples, all of which 
had an indication of co-colonization by the plyNCR-RFLP method. However, as both 
methods did not confidently discriminate between NT species within co-colonized samples, 
we decided to exclude all NT from further analysis to avoid possible over-reporting of true 
pneumococcal co-colonization. Hence, all results presented in this report involve only 
pneumococci for which serotypes were identified. Still, when a separate analysis was 
performed, assuming that all NT were bona fide non-encapsulated pneumococci, the same 
conclusions described below were obtained (data not shown). 
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Upon exclusion of all NTs, the microarray detected more than one pneumococcal serotype 
(i.e., more than one capsulated strain) in 73 samples that had an indication of co-
colonization. 
Confirmation of serotypes detected by the microarray. All serotypes identified by the 
microarray were confirmed by PCR using as template purified DNA of the primary selective 
growth. New primers, targeting specific capsule biosynthetic genes or variants not covered 
by the CDC scheme, were designed as needed (Supplementary Table 1). 
 Factors associated with pneumococcal co-colonization. Vaccination status and 
attendance of day-care center F were the only variables significantly associated with co-
colonization and both were protective factors (Table 1). Vaccinated children presented 
significantly lower (p=0.004; Fisher’s exact test) co-colonization rates (8.0%) than non-
vaccinated children (regardless of whether the latter were from the pre-PCV7 era (17.3%) or 













Figure 1. Frequency of co-colonization in the three study groups. 
 *Statistically significant differences (p=0.004; Fisher’s exact test) 
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Co-colonization patterns. Among the 73 co-colonized samples (excluding NT), the 
microarray identified two serotypes in 59 samples, three serotypes in 13 samples, and six 
serotypes in one sample (Table 2). When each type of co-colonization (double, triple, and 
sextuple) was analyzed separately, a higher proportion of each type of co-colonization was 
still noted among the unvaccinated children. However, probably due to the low number of 
observations, the results did not reach statistical significance (Table 2). 
 
Table 2. Colonization events according to study group.  
No. of serotypes 










1 143 (82.6) 138 (81.7) 138 (92.0) 419 (85.2) 0.018a 
> 1 
(all co-colonization samples) 
30 (17.3) 31 (18.3) 12 (8.0) 73 (14.8) 0.018a 
2 25 (14.4) 23 (13.6) 11 (7.3) 59 (12.0) 0.11a 
3 4 (2.3) 8 (4.7) 1 (0.7) 13 (2.6) 0.08b 
4 0 (-) 0 (-) 0 (-) 0 (-) - 
5 0 (-) 0 (-) 0 (-) 0 (-) - 
6 1 (0.6) 0 (-) 0 (-) 1 (0.2) 0.65b 
aҲ2 test 
bFisher’s exact test 
 
 
Serotype distribution. In line with previous observations, a significant serotype 
replacement effect (of vaccine types (VTs) by non-vaccine types (NVTs)) was observed 
among samples from the PCV7 era compared to samples from the pre-PCV7 era (Figure 2). 
This effect was noted both in single and co-colonization events and among vaccinated and 
non-vaccinated children, although it was more pronounced in the former group.  
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When the relative proportion of VTs in single and co-colonization in the pre-PCV7 and PCV7 
eras were compared, no significant changes were observed (p=0.338, Fisher exact test). 
However, this was not true for NVTs: in the PCV7 era there were significantly less NVT co-
colonization events than would be expected based on the NVT distribution observed in the 
pre-PCV7 era (p=0.024). This result, suggested that, in the PCV7 era, there was an 
asymmetric distribution among NVTs found in single or co-colonizing events. Such effect 
was more pronounced among vaccinated children (where serotype replacement effect was 











Furthermore, the distribution of individual serotypes found in co-colonized samples reflected, 
in general, the distribution found in samples containing a single strain, i.e., serotypes 
frequent in single colonization tended to be also frequent in co-colonization (Figure 3). 
Serotypes 19F and 23F were the most frequent colonizers of the nasopharynx in the pre-
PCV7 era and serotypes 6A and 19A dominated in the PCV7 era. 
Figure 2. Single and co-colonization events by vaccine-types (VT) and non-vaccine 
types (NVT) in the three study groups.  























Relative abundance of serotypes of co-colonized samples. For each co-colonization 
event the relative proportion of each serotype was determined by the microarray. We 
observed that there was a clear dominance of one serotype over the other(s) in a sample in 
71.9% the cases involving associations of NVTs. In the associations of two or more VTs, or 
VTs with NVTs, this dominance was not so evident being 62.5% and 42.4%, respectively. 
Figure 3. Individual serotype distribution of single and co-colonized samples from the pre-
PCV7 and PCV7 eras.  Non-vaccine serotypes with an absolute frequency <5 in the PCV7 era were 
grouped as “others”. These include serotypes 8, 9L, 9N, 13, 15A, 17F, 18A, 18F, 19B, 19C, 22F, 24F, 
29/35B, 31, 33A/33F, 34, 38, 42, 33B-like, 35A/C, 36/15B-like, and 39-like. *Observed frequency in 
co-colonization is significantly lower than expected. 
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To investigate if individual serotypes had been detected in co-colonization at a frequency 
significantly different from the one expected by chance alone, a permutation analysis was 
done for each time period. Serotypes 9V and 19F (in the pre-PCV7 era), and 6A, 6C, 10A, 
11A/11D, 14, 15B/C, 16F, 19A, 21, and 23A (in the PCV7 era) were found less frequently in 
co-colonization than expected (Figure 3). A more detailed analysis aimed to detect specific 




We aimed to study the impact of PCV7 on pneumococcal co-colonization rates by combining 
two recently developed methods, ply-NCR RFLP and molecular serotyping microarray, 
which enabled detection of co-colonization and the identification and relative quantification of 
the serotypes present in those samples.  
After excluding NT species, a co-colonization rate by capsulated pneumococci of 
approximately 15%, confirmed by both the plyNCR-RFLP and microarray methods was 
observed. The combination of these two methods allowed four times more sensitivity in 
detection of co-colonization than serotyping of individual colonies exhibiting distinct 
morphologies. 
Our results show that introduction of PCV7 led to a serotype replacement effect among 
vaccinated children and, although less pronounced, also among non-vaccinated children. As 
a result, in the PCV7 era, a decrease in the proportion of VTs was observed in single and 
co-colonized carriers of both groups. These findings are in line with previous observations 
that indicated that, in settings where vaccination rates are high, vaccination reduces not only 
the proportion of vaccinated individuals colonized with VTs but also among non-vaccinated 
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individuals in the community due to an indirect effect resulting from decreased transmission 
of VTs (Weinberger et al., 2011). 
Interestingly, co-colonization rates were significantly lower among vaccinated children 
(8.0%) than among non-vaccinated children (c.a. 18%, irrespective of whether they were 
from the pre-PCV7 or PCV7 eras). Of the variables studied, attendance of day-care center F 
and, more importantly, vaccination status were the only factors that accounted for these 
phenomena. 
Comparison of the characteristics of day-care center F with the other 14 day-care units did 
not reveal obvious differences between them (in carriage prevalence, area, number of 
children, crowding, or antimicrobial consumption). However, this center was enriched on 
serotypes (6A, 11A/D, and 19A) known to be less associated with co-colonization than 
expected by chance alone (as discussed below) which, per se, could potentially explain this 
observation.  
The finding that co-colonization was diminished among PCV7-vaccinated children is of 
particular interest as it may have important implications for pneumococcal evolution. Indeed, 
decreased co-colonization is expected to translate in fewer opportunities for horizontal gene 
transfer hindering, for example, transference of resistance genes and emergence of vaccine 
escape recombinants.  
But how to explain such observations?  A closer inspection of Figure 2 indicates that among 
vaccinated children a significant reduction of VTs led to an asymmetric redistribution of the 
proportion of single and multiple NVT carriers. Specifically, it resulted in a higher than 
expected proportion of single NVT carriers and a lower than expected proportion of 
NVT/NVT multiple carriers.  
One possible interpretation for the latter observation is that some NVTs in circulation in the 
PCV7 era are more competitive than others, impairing their co-existence in the same 
ecological niche. Evidence for competition between serotypes in the nasopharynx was 
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described before and mechanisms leading to it (such as bacteriocin production) have been 
identified (Claverys & Havarstein, 2007; Lipsitch et al., 2000). Two observations in the study 
support this hypothesis: (i) the fact that in the association of two or more NVTs, there was a 
clear dominance of one serotype in 71% of the cases, while such high values were not 
observed in the association of two or more VTs (63%) or in the association of VTs with NVTs 
(42%); and (ii) in the PCV7 era, there were a number of NVTs that were found less 
frequently in co-colonization than would be predicted by chance alone. These serotypes 
were among the group of the most prevalent ones in single colonization for the same period 
suggesting they are highly competitive.  
Our results contrast with those from a recent study in Switzerland that reported a stable rate 
of co-colonization upon introduction of PCV7 and a balanced co-existence of serotypes 
found in co-colonized samples (Brugger et al., 2010). That study, however, differs from ours 
in several aspects hindering comparisons between findings. The study population consisted 
of patients with acute otitis media or pneumonia (and hence, not healthy), children and 
adults were included, colonization rates were significantly lower (even when the same age 
groups were compared), and the starting material was the swab without a culturing step. 
Furthermore, if competition between serotypes is indeed relevant, local serotype distribution 
may further affect the results obtained. Additional studies are warranted to explore this 
subject. 
Of note, we observed that in our setting (as in many others), in the vaccine era, serotypes 
6A and 19A were the most frequent colonizers of the nasopharynx in single and co-
colonization. As the recently introduced PCV13 includes these two serotypes, it will be 
important to monitor how co-colonization is affected by it. 
Our study has some limitations. Firstly, it is a cross-sectional study and therefore duration of 
carriage, known to vary according to the serotype, was not taken into account (Gray et al., 
1980). This has at least two implications: on one hand, the co-colonization rate may have 
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been underestimated as serotypes with shorter duration of carriage may have been missed; 
on the other hand, we were unable to determine whether the co-colonized samples result 
from a truly co-existence colonization event or merely reflect a transitional state between 
serotypes colonizing the nasopharynx.  
Secondly, the direct culture of the nasopharyngeal swab has some disadvantages. As with 
any culturing step, the chance of occurrence of sample contamination during handling 
increases. In addition, variation in the inoculum size may have occurred. This could have 
been partially overcome if the swab would have been first diluted in a liquid medium and, 
afterwards, a fixed amount of the liquid sample plated. Also, the use of a cultivation step and 
the choice of a selective (gentamycin blood agar) medium may have altered the composition 
of the sample. Finally, the culturing step may lead to false-negative results (as we analyzed 
viable cells only). Still, despite these limitations, our strategy has the advantage of increasing 
the amount of pneumococcal DNA in the samples. Direct analysis of the swabs often leads 
to limited amounts of DNA hindering further processing of the sample; for example in a 
previous study using the plyNCR-RFLP method, 21% of the samples did not yield sufficient 
DNA for analysis (Brugger et al., 2009).  
The third limitation is the current inability of the microarray to discriminate between non-
encapsulated pneumococci from other closely related Streptococcus spp. such as S. mitis 
when within a complex mixture containing other pneumococci. In this study, we ignored the 
presence of these NT organisms but a separate analysis taking into account these results 
mimicked the general observations reported here. However, co-colonization with non-
encapsulated pneumococcus or closely related species is of interest as this represents the 
wider gene pool available for horizontal gene transfer. 
Finally, the inclusion of older children (up to 71 months) might be considered a limitation as it 
is not clear whether conjugate vaccines administered in the first and second year of life will 
have an effect on colonization 3-4 years afterwards. Still, a previous study by Millar et al. on 
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the long-term effect of PCV in a community using a 3+1 schedule, found a significantly lower 
prevalence of VT carriage 27 months after vaccination when compared with control 
communities (Millar et al., 2006), suggesting there might be a prolonged effect of PCV7 on 
colonization. Furthermore, if we consider the opposite scenario, that is, that children of older 
ages are no longer protected by PCV7 then we would expect this group to have higher 
carriage of VTs, which would lead to a net increase in VT among the vaccinated group. This, 
in turn, according to our data, would result in a global increase in co-colonization among this 
group. In other words, the results presented by us for the vaccinated group would have a 
bias towards an increasing co-colonization rate. Still, the rate observed was significantly 
lower than among non-vaccinated children supporting our observations and suggesting that, 
if anything, the exclusion of older children would result in a even stronger disparity between 
co-colonization rates among vaccinated and unvaccinated children. 
Our study has also some strength. The collection of samples used was well defined and 
matched and the methods used have high sensitivity. This allowed us to take some 
important conclusions in the context of co-colonization. Finally, we are convinced that, to our 
knowledge, this is one of the very few studies to date focusing on the impact of PCV7 on 
pneumococcal multiple carriage and is the first to report a significant difference between co-
colonization rates of vaccinated and non-vaccinated children. 
In summary, this study suggests that PCV7-vaccinated children have lower rates of 
pneumococcal co-colonization, resulting in decreased opportunities for horizontal gene 
transfer between strains. This represents a novel potential benefit of multivalent 
pneumococcal conjugate vaccines. Considering that these results may depend on local 
epidemiological factors and that serotype redistribution is occurring as novel vaccines are 
being introduced, additional studies are warranted to verify if similar results are obtained. 
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Primer sequence (5’-3’) 
wchL_15B_f 
































39 wcrD 562 
5’-GGTGGACATGGGTCAACGATTAATGTTGGT-3’ 
wcrD _39_r 5’-AGTATGTCAATACGTCTCTGACTACTGG-3’ 
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Table S2. Age distribution in the three groups. 
Age (yr) 
No. of children per group (%) 
Pre-PCV7 period 
PCV7 period 
 (0 doses) 
PCV7  period 
(4 doses) 
<2 15 (8.7) 4 (2.4) 11 (7.3) 
2-<4 50 (28.9) 58 (34.3) 63 (42.0) 
4-<6 108 (62.4) 107 (63.3) 76 (50.7) 
Total: 173 169 150 
Comparison of age distribution in the three groups was done by a Kolmogorov-Smirnov 
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Summary 
Introduction: Pneumococcal multiple serotype carriage is important for evolution of 
the species and to understand how the pneumococcal population is changing with 
vaccination. We aimed to determine the impact of the 13-valent pneumococcal 
conjugate vaccine (PCV13) on multiple serotype carriage.  
Methods and Materials: Nasopharyngeal samples from fully vaccinated 
pneumococcal carriers (4 doses of PCV13, n=141, aged 18-72 months) or from non-
vaccinated pneumococcal carriers (0 doses of any PCV, n=140, same age group) were 
analyzed. Multiple serotype carriage was evaluated by DNA hybridization with a 
molecular serotyping microarray that detects all known serotypes.  
Results: Vaccinated children had a lower prevalence of multiple serotype carriage than 
the non-vaccinated group (20.6% vs 29.3%, p=0.097), and a significantly lower 
proportion of PCV13 serotypes (6.4% vs 38.5%, p=0.0001). PCV13 serotypes found 
among vaccinated children were mostly detected as a minor serotype in co-
colonization with a more abundant non-vaccine serotype. Vaccinated children were 
colonized by a significantly higher proportion of commensal non-pneumococcal 
Streptococcus spp. (58.2% vs 42.8%, p=0.012). In vaccinated children there were 
significantly less non-vaccine type (NVT) co-colonization events than expected based 
on the distribution of these serotypes in non-vaccinated children.  
Conclusions: The results suggest that vaccinated children have lower pneumococcal 
multiple serotype carriage prevalence due to higher competitive abilities of non-vaccine 
serotypes expanding after PCV13 use. This might represent an additional benefit of 
PCV13, as decreased co-colonization rates translate into decreased opportunities for 





Streptococcus pneumoniae is an important cause of infectious disease, with a high rate 
of mortality worldwide, particularly among young children, the elderly and the 
immunocompromised (O'Brien et al., 2009). 
Despite the high burden, invasive pneumococcal disease is incidental (Bogaert et al., 
2004 ; CDC, 2012). Nasopharyngeal colonization is the natural lifestyle for the 
pneumococcus, with particularly high prevalence among young children (Gray et al., 
1980). Colonization is key in pneumococcal biology as it precedes disease, facilitates 
transmission between hosts for perpetuation of the species; and allows sustained 
evolution of the species to take place.  
The pneumococcus evolves mainly by recombination through horizontal gene transfer 
(HGT) occurring when multiple strains or serotypes of pneumococci coexist, a 
phenomenon also known as co-colonization. Likewise, HGT with closely related co-
colonizing commensals such as S. mitis and S. pseudopneumoniae can also occur 
(Kilian et al., 2008). 
Co-colonization or multiple serotype carriage is frequent. Recent studies reported 
multiple serotype carriage prevalence of up to 40% in children (Kamng'ona et al., 2015; 
Kandasamy et al., 2015; Valente et al., 2012). An accurate detection of multiple 
serotype carriage in surveillance studies is relevant (i) for the understanding of the 
intra-species interactions, (ii) to obtain a comprehensive knowledge of how the 
pneumococcal population is being altered by anti-pneumococcal vaccination, and (iii) to 
predict the vaccine impact on disease when using models based on carriage 
prevalence (Brueggemann et al., 2003; Sá-Leão et al., 2011; van Hoek et al., 2014).  
In recent years, with the increasing availability of highly sensitive serotyping methods 
that are able to detect multiple serotype carriage, reports on co-colonization are 
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becoming more frequent (Brugger et al., 2010; Kamng'ona et al., 2015; Kandasamy et 
al., 2015; Turner et al., 2011; Valente et al., 2012). In a previous study conducted to 
determine the prevalence of multiple serotype carriage among Portuguese children and 
the impact of vaccination with the 7-valent pneumococcal conjugate vaccine (PCV7), 
we demonstrated that PCV7 vaccinated children were significantly less co-colonized 
than non-vaccinated children due to an uneven distribution of serotypes selected by 
PCV7 in single and co-colonization events (Valente et al., 2012). 
The 13-valent pneumococcal conjugate vaccine (PCV13) became commercially 
available in Portugal in January 2010 replacing PCV7. Although at the time of this 
study none were introduced in the National Immunization Program (NIP), these 
vaccines are highly prescribed and their usage has been recommended by the 
Portuguese Pediatric Society . For this reason, vaccine coverage has been high, 
reaching 63% by 2012 (data from the National Statistics Institute (INE) and IMS). Very 
recently, in June 2015, PCV13 was introduced in the NIP on a scheme of two doses 
followed by a booster dose. 
The impact of PCV13 on carriage is being studied in several countries and there are 
already some studies addressing this issue (Chang et al., 2015; Gladstone et al., 2015; 
Steens et al., 2015). However, to our best knowledge the impact of this vaccine on 
carriage of multiple serotypes and co-colonization with other Streptococcus spp. has 
not been addressed. 
The aims of this study were to determine the impact of PCV13 on pneumococcal 
multiple serotype carriage and to compare the results with those obtained for PCV7. 
 
Materials and methods 
Study design. Nasopharyngeal (NP) swabs collected from healthy children attending 
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day-care centers in Oeiras and Montemor-o-Novo, Portugal, were retrospectively 
selected. Samples were collected in the winter months of January to March between 
2011 and 2015. The following criteria were used for selection of samples to be 
analyzed in this study: (i) swabs were obtained from children aged 18-71 months; (ii) 
children had not received antibiotic within the month preceding sampling; and (iii) 
swabs yielded a pneumococcal positive culture.  
Samples were clustered into two groups: one group included samples collected from 
children who had not been vaccinated with any PCV (n=150); the other group included 
samples collected from fully PCV13-vaccinated children, i.e., children who had 
received 4 vaccine doses (n=150).  
Ethics statement. This study was approved by the Ethics Research Committee of the 
NOVA Medical School/Faculdade de Ciências Médicas - New University of Lisbon 
(CEFCM) (47/2014/CEFCM). Samples were collected upon signed informed consent 
from the parents or guardians of participating children. All information was processed 
anonymously. 
Sample collection and isolation of pneumococci. NP samples were collected by 
pediatric nurses. In 2011 and 2012 mini-tip calcium alginate sterile swabs were used 
and inoculated directly within 4 hours in a primary selective plate of 5% blood trypticase 
soy agar containing gentamicin (5 mg/liter) to select for S. pneumoniae. Samples from 
2014 and 2015 were collected and isolated according to the standard procedures 
recommended by the WHO (Satzke et al., 2014). Swabs, the total bacterial lawn of the 
primary gentamicin blood plate and pneumococcal isolates were frozen at -80ºC in 1ml 
of STGG medium containing 30% glycerol. 
DNA isolation. STGG tubes containing the nasopharyngeal swab were thawed on ice 
and vortexed. 50 µl aliquots were plated onto tryptic soy blood plates supplemented 
with gentamicin using a spreader and incubated overnight at 37ºC in 5% CO2. On the 
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following day, a plate sweep of the total bacterial growth was collected and DNA was 
extracted with the DNeasy Blood and Tissue Kit (Qiagen, Germany).  
Detection of multiple serotype carriage by microarray. The BµG@S SP-CPSv1.5.0 
S. pneumoniae molecular serotyping microarray was used following standard protocols 
previously described (Brugger et al., 2010; Turner et al., 2011). Genomic DNA ULS 
labeling and hybridization protocols were used and microarray slides were scanned 
using a high-resolution microarray scanner (Agilent Technologies, USA). Microarray 
data was analyzed using a Bayesian hierarchical model to determine the serotype, or 
combination of serotypes, present in the sample and to assign their relative abundance 
(Newton et al., 2011). For the interpretation of the microarray quantification results, a 
serotype was classified according to its relative abundance in the sample as: dominant 
if ≥70%; co-dominant if >30% and <70% and minor if ≤30%. 
Statistical analysis. Statistical significance was accessed through Fisher’s exact tests. 
For all analyses differences were considered statistically significant when p<0.05. 
 
Results 
Microarray serotyping and detection of co-colonization. The microarray analysis 
detected S. pneumoniae DNA in a total of 281 samples – 140 samples collected from 
non-vaccinated children and 141 samples collected from vaccinated children. Samples 
in which the microarray failed to detect pneumococcal DNA were excluded from the 
study (n=19). In four of these samples one encapsulated pneumococcal strain had 
been isolated before, but probably due to low abundance and sampling, it was not 
detected when the DNA of the primary culture was probed in the microarray. In the 
remaining 15 samples, putative non-encapsulated pneumococci were isolated and 
were later confirmed to be strains of other closely related Streptococcus spp. 
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Among the 281 samples containing pneumococci, the microarray identified 345 
pneumococcal strains of known serotypes, 30 pneumococcal strains of non-
encapsulated lineages (herein called non-typeable or NT) and 302 Streptococcus spp. 
strains. The pneumococcal population was distributed throughout 40 serotypes and NT 
strains (Figure 1). Pneumococcal co-colonization was detected in 25% of the samples 
(70 out of 281 samples). Half of the samples (50.5%) contained at least one 
Streptococcus spp. strain in addition to S. pneumoniae.  
 
 
The microarray identified three types of non-typeable non-encapsulated pneumococci 
that are genetically distinct: NT2, NT3b and NT4b detected in 1.1%, 7.5%, and 2.1% of 
the samples, respectively (Park et al., 2012; Salter et al., 2012). For subsequent 
analysis we have grouped non-encapsulated strains into a single group (NT), which 
was collectively the most prevalent pneumococcal type.  
The most abundant Streptococcus species (other than pneumococci) identified were S. 
mitis, S. oralis, S. infantis and S. salivarius present in 46.3%, 34.9%, 32.7% and 30% 
of the samples, respectively. Other species identified included S. pseudopneumoniae, 
S. sanguinis, S. constellatus, S. anginosus and S. intermedius, present in up to 5% of 
the samples. Among these samples, in some cases the microarray detected the 
presence of a few capsule biosynthesis gene homologues, but never the full 
complement of cps genes expected for any known pneumococcal serotypes. 
Figure 1. Serotype ranking in the study population obtained through the detection of 
single and co-colonization events.  
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In general, serotypes found in co-colonization had comparable frequencies as minor or 
non-minor serotypes. The exception to this scenario were NT pneumococci, which 
were found as minor serotype in the majority of co-colonization events (p=0.0164, 
Fisher’s exact test) (Figure S1). Still, the ranking frequencies of several serotypes 
would change if only the dominant serotype in the samples had been detected (Figure 
S1). 
Pneumococcal co-colonization in PCV13 vaccinated and non-vaccinated carriers. 
The prevalence of pneumococcal multiple serotype carriage among PCV13 vaccinated 
carriers was lower (20.6%) than among the non-vaccinated group (29.3%), although 
the difference was not statistically significant (p=0.0973, Fisher’s exact test). In both 
groups most multiple serotype carriage samples contained two serotypes and a 
maximum of four serotypes were detected in 5 samples. In multiple serotype carriage 
samples, a clear dominance of one serotype was noted in most cases with no 
significant differences between the two groups (Table 1).  
a Fisher’s exact test. 
Table 1. Comparison between nasopharyngeal samples obtained from PCV13 
vaccinated and non-vaccinated pneumococcal carriers 
Characteristic 
PCV13 vaccinated  
 (total=141)  
n, (%) 
Non-vaccinated  
 (total=140)  
n, (%) 
p-valuea 
    
Multiple serotype carriage 29 (20.6%) 41 (29.3%) 0.0973 
    



































Overall carriage of PCV13 vaccine types was significantly lower in the vaccinated 
group, compared to the non-vaccinated group (6.4% vs 38.5%, p=0.0001, Fisher’s 
exact test). However, when single and multiple serotype carriage events were analyzed 
separately, the trend was maintained but only reached statistical significance in single 
carriage events (2.1% (3/141) vs. 26.4% (37/140), p<0.0001 in single carriage and 












Among the few (n=9) vaccinated children that carried PCV13 serotypes, six had them 
in co-colonization with a non-vaccine type (NVT); in five of these events the vaccine 
type was in minority. By contrast among the 54 non-vaccinated children that carried 
PCV13 serotypes, in the majority (37, 69%) it was found as a single serotype. In the 
remaining carriers, PCV13 serotypes were found in co-colonization and were dominant 
in the majority of the events (11 of 17) (Figure 3). 
 
Figure 2. Single and co-colonization events by PCV13 vaccine types (VT) and 
non-PCV13-vaccine types (NVT) in PCV13 vaccinated and non-vaccinated 
children. Asterisks indicate total prevalence of multiple serotype carriage. 


















































































































































































































































































Of note, serotype 19F accounted for 40% (n=26 out of 66) of all PCV13 strains 
identified by the microarray and was the most prevalent PCV13 serotype in vaccinated 
and non-vaccinated children, both in single and co-colonization events (Figure 3). 
Of all types, NT strains were the most prevalent pneumococcal type identified in single 
and multiple carriage events, being present in 11.4% of co-colonized samples. Apart 
from type NT3b which was found as a dominant strain in three multiple carriage events, 
all non-encapsulated strains were found co-colonizing as a minor serotype.  
Serotype distribution. Comparison of the two groups of carriers concerning the 
relative fraction of VTs occurring in single and multiple serotype carriage events 
revealed no differences between vaccinated and non-vaccinated children (26.4/12.1 vs 
2.1/4.3, p=0.0626, Fisher’s exact test, Figure 2). In contrast, the same comparison for 
NVTs showed that the relative fraction of these serotypes occurring in single and co-
colonization events was different among the two groups: 77.3/20.6 in vaccinated vs 
44.3/27.8 in non-vaccinated carriers (p=0.036, Fisher’s exact test) (Figure 2).  
Associations in co-colonization. We investigated associations among the co-
colonized samples. As the number of serotypes present in co-colonization was high 
(n=38), the frequency in which specific pairs of serotypes were found together was low. 
Vaccinated children were co-colonized by a lower number of serotypes (n=26) 
compared to the non-vaccinated group (n=35), which translated in a less complex 
network of dual interactions (Figure 4).  
Among vaccinated co-colonized children the most frequent pneumococcal types were 
NT strains and serotypes 16F, 11A 15B/C and 21. Among non-vaccinated co-colonized 
children the most frequent types were NT, 19F, 23B, 6C, 15B/C, and 16F. 
Carriage prevalence of other Streptococcus spp. was high in both groups but 
significantly higher in vaccinated children, compared to the non-vaccinated group 
(58.2% vs 42.8%, p=0.0122, Fisher’s exact test) (Figure 4).  





The most frequent association detected was between non-typeable pneumococci and 
non-pneumococcal Streptococcus spp. Other frequent associations of S. pneumoniae 
serotypes were 19F-NT, 15B/C-NT, 6C-NT (Figure 4). 
 
Discussion 
We have used a molecular serotyping microarray to evaluate the impact of PCV13 on 
pneumococcal multiple serotype carriage, through the comparison of a group of 
children who had received four PCV13 doses with another group that had not been 
vaccinated with any PCV. This method was recently described as the top-performing 
method currently available to study multi-serotype carriage (Satzke et al., 2015). 
Figure 4. Node plot of strains co-colonizing non-vaccinated and vaccinated children. The 
size of each node is proportional to the number of interactions in which each serotype is found. 
The width of the edges is proportional to the frequency in which two serotypes are found together. 
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The results show that vaccinated children had lower multiple serotype carriage 
prevalence, compared to the non-vaccinated group (29.3% vs 20.6%), although the 
difference between groups was not statistically significant.  
As expected, we observed that use of PCV13 in Portugal has led to serotype 
replacement in vaccinated children, a result that is in line with those observed in other 
countries (Moore et al., 2015; Waight et al., 2015). The use of the microarray has 
shown that vaccinated children not only carry less VTs but also tend to have them as a 
minor serotype in multiple carriage with a NVT. On the other hand, among non-
vaccinated children carriage of VTs is frequent and often found in single carriage 
events. When in multiple carriage VTs tend to be the dominant type in this naïve group.  
Moreover, we observed that vaccinated children were colonized by a lower number of 
serotypes and had a higher prevalence of NT and Streptococcus spp., compared to the 
non-vaccinated group, suggesting niche replacement by less virulent strains. This 
observation suggests that PCVs, by eliminating highly competitive serotypes from the 
nasopharyngeal niche, are allowing the expansion of commensal streptococci. This 
hypothesis is further supported by a study in which the nasopharyngeal microbiota 
profiles of vaccinated and non-vaccinated children were compared, showing expansion 
of other Streptococcus spp. and other commensals in vaccinated children (Biesbroek et 
al., 2014). 
Yet another difference observed between vaccinated and non-vaccinated children was 
the asymmetric distribution of NVTs in single and multiple carriage events when the 
two groups were compared. In vaccinated children the proportion of multiple carriage 
events with NVTs was lower than it would be expected by chance alone, based on the 
prevalence of these types in the non-vaccinated group. This observation supports that 
pneumococcal serotypes have different competitive abilities (Lipsitch et al., 2000; 
Trzcinski et al., 2015; Valente et al., 2012) and that some NVTs that became more 
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prevalent following PCV13 introduction might be highly competitive, preventing their co-
existence with other pneumococci. This hypothesis might also explain why vaccinated 
children, where serotype replacement is more pronounced, present lower co-
colonization prevalence.  
The results obtained in this study are in agreement with a previous study with a similar 
aim conducted in the PCV7 era (Valente et al., 2012). In both studies we found lower 
co-colonization rates among vaccinated children and an asymmetric distribution of 
NVTs in single and multiple carriage events in this group. Results from both studies 
seem to suggest that PCVs might have the additional benefit of decreasing 
pneumococcal co-colonization events, and thus, the opportunities for horizontal gene 
transfer in pneumococci (Hiller et al., 2010). In addition, it is possible that our 
observations reflect a transient phenomenon of early vaccine effect before equilibrium 
on serotype distribution has been reached. 
Our study has some limitations. First, there were differences in the methodology for 
isolation of S. pneumoniae in the years of 2011/2012, compared to 2014/2015 that 
could potentially interfere with results. To rule out this possibility, all analyses were 
repeated excluding samples from 2011 and 2012 and the results obtained mimicked 
the ones reported in this study, apart from the difference in carriage of Streptococcus 
spp. between vaccinated and non-vaccinated children, which became non-significant 
but still showed the same trend. Second, the culturing step of the nasopharyngeal 
swab could potentially have altered the composition of the sample and, thus, interfere 
with the detection and relative quantification of pneumococci, or induce a bias towards 
the detection of viable cells only, resulting in false-negative results. Nevertheless, we 
are convinced that the increase in the total pneumococcal DNA induced by the 
culturing step is an advantage that surmounts the referred limitations, as direct analysis 
of swab DNA results in a lower sensitivity of the microarray for detection of the low 
abundant minor serotypes.  
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Our study has also some strength. To our knowledge, this is the first study focusing on 
the impact of PCV13 on pneumococcal co-colonization, reporting differences between 
vaccinated and non-vaccinated children that might represent novel benefits of PCVs. 
Also, the use of a highly sensitive microarray allowed us to detect minor serotypes that 
would otherwise be missed, and to assess how the pneumococcal population structure 
might be altered by the detection of those serotypes, namely by the unmasking of 
some serotypes that might be more prevalent than initially thought. In addition, 
because the microarray incorporates all capsule biosynthesis genes, plus reporters for 
the S. pneumoniae genome backbone and species discrimination, the use of this 
methodology allowed us to correctly identify pneumococcal strains and to report on the 
prevalence of closely related Streptococcus spp. 
A word of caution regarding our study is the fact that we cannot exclude the hypothesis 
that the observed effect of PCV13 on co-colonization might by restricted to the 
population studied here. Although we have now addressed this effect of PCVs on co-
colonization twice with concordant results (Valente et al., 2012), the observed effects 
might be a consequence of the serotype distribution in our setting. Additional studies 
would be of interest to ascertain whether this is the case. 
In summary, this study corroborates our previous observations regarding the impact of 
conjugate vaccines on pneumococcal co-colonization, showing that vaccinated children 
have lower multiple serotype carriage rates than non-vaccinated children. This 
observation has implications for the virulence and evolution of pneumococci, as it might 
result in decreased opportunities for horizontal gene transfer between strains. Of note, 
we show a very high prevalence of non-encapsulated pneumococci and Streptococcus 
spp., particularly among vaccinated children. The role of these species in the 
nasopharyngeal ecosystem and in the evolution of pneumococci are questions that 
remain to be addressed but overall our findings suggest a niche evolution towards 
commensality. 
Impact of PCV13 on pneumococcal co-colonization 
91 
Funding 
This work was funded by an unrestricted research grant from Pfizer to RSL and by 
Fundação para a Ciência e a Tecnologia through R&D Unit, UID/CBQ/04612/2013 and 
through grant SFRH/BD/70058/2010 to CV.The funders had no role in the design of the 
study, collection, analysis, and interpretation of data, writing of the manuscript or in the 
decision to submit the manuscript for publication.  
 
References 
Biesbroek, G., Wang, X., Keijser, B. J., Eijkemans, R. M., Trzcinski, K., Rots, N. Y., 
Veenhoven, R. H., Sanders, E. A. & Bogaert, D. (2014). Seven-valent pneumococcal 
conjugate vaccine and nasopharyngeal microbiota in healthy children. Emerg Infect Dis 20, 201-
210. 
 
Bogaert, D., De Groot, R. & Hermans, P. W. (2004). Streptococcus pneumoniae colonisation: 
the key to pneumococcal disease. Lancet Infect Dis 4, 144-154. 
 
Brueggemann, A. B., Griffiths, D. T., Meats, E., Peto, T., Crook, D. W. & Spratt, B. G. 
(2003). Clonal relationships between invasive and carriage Streptococcus pneumoniae and 
serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187, 1424-
1432. 
 
Brugger, S. D., Frey, P., Aebi, S., Hinds, J. & Muhlemann, K. (2010). Multiple colonization 
with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal 
polysaccharide vaccine. PLoS One 5, e11638. 
 
CDC (2012). Epidemiology and Prevention of Vaccine-Preventable Diseases - Pneumococcal 
Disease. In The Pink Book: Course Textbook. Atlanta. 
 
Chang, Q. Z., Stevenson, A. E., Croucher, N. J., Lee, G. M., Pelton, S. I., Lipsitch, M., 
Finkelstein, J. A. & Hanage, W. P. (2015). Stability of the pneumococcal population structure 
in Massachusetts as PCV13 was introduced. Bmc Infectious Diseases 15. 
 
Gladstone, R. A., Jefferies, J. M., Tocheva, A. S., Beard, K. R., Garley, D., Chong, W. W., 
Bentley, S. D., Faust, S. N. & Clarke, S. C. (2015). Five winters of pneumococcal serotype 
replacement in UK carriage following PCV introduction. Vaccine 33, 2015-2021. 
 
Gray, B. M., Converse, G. M., 3rd & Dillon, H. C., Jr. (1980). Epidemiologic studies of 
Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 
months of life. J Infect Dis 142, 923-933. 
 
Hiller, N. L., Ahmed, A., Powell, E. & other authors (2010). Generation of genic diversity 
among Streptococcus pneumoniae strains via horizontal gene transfer during a chronic 




Kamng'ona, A. W., Hinds, J., Bar-Zeev, N. & other authors (2015). High multiple carriage 
and emergence of Streptococcus pneumoniae vaccine serotype variants in Malawian children. 
BMC Infect Dis 15, 234. 
 
Kandasamy, R., Gurung, M., Thapa, A. & other authors (2015). Multi-serotype pneumococcal 
nasopharyngeal carriage prevalence in vaccine naive Nepalese children, assessed using 
molecular serotyping. PLoS One 10. 
 
Kilian, M., Poulsen, K., Blomqvist, T., Havarstein, L. S., Bek-Thomsen, M., Tettelin, H. & 
Sorensen, U. B. (2008). Evolution of Streptococcus pneumoniae and its close commensal 
relatives. PLoS One 3, e2683. 
 
Lipsitch, M., Dykes, J. K., Johnson, S. E., Ades, E. W., King, J., Briles, D. E. & Carlone, G. 
M. (2000). Competition among Streptococcus pneumoniae for intranasal colonization in a 
mouse model. Vaccine 18, 2895-2901. 
 
Moore, M. R., Link-Gelles, R., Schaffner, W. & other authors (2015). Effect of use of 13-
valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in 
children and adults in the USA: analysis of multisite, population-based surveillance. Lancet 
Infectious Diseases 15, 301-309. 
 
Newton, R., Hinds, J. & Wernisch, L. (2011). Empirical Bayesian models for analysing 
molecular serotyping microarrays. BMC Bioinformatics 12, 88. 
 
O'Brien, K. L., Wolfson, L. J., Watt, J. P. & other authors (2009). Burden of disease caused 
by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374, 
893-902. 
 
Park, I. H., Kim, K. H., Andrade, A. L., Briles, D. E., McDaniel, L. S. & Nahm, M. H. (2012). 
Nontypeable pneumococci can be divided into multiple cps types, including one type expressing 
the novel gene pspK. MBio 3. 
 
Sá-Leão, R., Pinto, F., Aguiar, S. & other authors (2011). Analysis of invasiveness of 
pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate 
vaccines reveals heterogeneous behavior of clones expressing the same serotype. J Clin 
Microbiol 49, 1369-1375. 
 
Salter, S. J., Hinds, J., Gould, K. A. & other authors (2012). Variation at the capsule locus, 
cps, of mistyped and non-typable Streptococcus pneumoniae isolates. Microbiology-Sgm 158, 
1560-1569. 
 
Satzke, C., Turner, P., Virolainen-Julkunen, A. & other authors (2014). Standard method for 
detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations 
from the World Health Organization Pneumococcal Carriage Working Group. Vaccine 32, 165-
179. 
 
Satzke, C., Dunne, E. M., Porter, B. D., Klugman, K. P. & Mulholland, E. K. (2015). The 
PneuCarriage Project: a multi-centre comparative study to identify the best serotyping methods 
for examining pneumococcal carriage in vaccine evaluation studies. PLoS Med 12, e1001903. 
 
SIP & SPP (2014). Comissão de Vacinas da Sociedade de Infecciologia Pediatrica (SIP) e 
Sociedade Portuguesa de Pediatria (SPP). Recomendações sobre vacinas: actualização 2014. 
Edn.28. 
 
Steens, A., Caugant, D. A., Aaberge, I. S. & Vestrheim, D. F. (2015). Decreased carriage and 
genetic shifts in the Streptococcus pneumoniae population after changing the 7-valent to the 13-
valent pneumococcal vaccine in Norway. Pediatr Infect Dis J. 
 
Impact of PCV13 on pneumococcal co-colonization 
93 
Trzcinski, K., Li, Y., Weinberger, D. M., Thompson, C. M., Cordy, D., Bessolo, A., Malley, 
R. & Lipsitch, M. (2015). Effect of serotype on pneumococcal competition in a mouse 
colonization model. MBio 6. 
 
Turner, P., Hinds, J., Turner, C., Jankhot, A., Gould, K., Bentley, S., Nosten, F. & 
Goldblatt, D. (2011). Improved detection of nasopharyngeal co-colonization by multiple 
pneumococcal serotypes using latex agglutination or molecular serotyping by microarray. J Clin 
Microbiol. 
 
Valente, C., Hinds, J., Pinto, F., Brugger, S. D., Gould, K., Mühlemann, K., de Lencastre, H. 
& Sá-Leão, R. (2012). Decrease in pneumococcal co-colonization following vaccination with the 
seven-valent pneumococcal conjugate vaccine. PLoS One 7, e30235. 
 
van Hoek, A. J., Sheppard, C. L., Andrews, N. J., Waight, P. A., Slack, M. P. E., Harrison, T. 
G., Ladhani, S. N. & Miller, E. (2014). Pneumococcal carriage in children and adults two years 
after introduction of the thirteen valent pneumococcal conjugate vaccine in England. Vaccine 
32, 4349-4355. 
 
Waight, P. A., Andrews, N. J., Ladhani, S. N., Sheppard, C. L., Slack, M. P. & Miller, E. 
(2015). Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal 
disease in England and Wales 4 years after its introduction: an observational cohort study. 



















Figure S1. Frequency of serotype occurrences as minor or dominant/co-dominant strain in 
multiple serotype carriage events. Minor serotype defined as having a relative abundance ≤30% 
of total pneumococcal DNA; Dominant/co-dominant serotype defined as having a relative 
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C. Valente performed all the analyses. This study was nested in the studies presented 
in Chapters II and III. 
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To the Editors: 
The introduction of multivalent pneumococcal conjugate vaccines has led to changes 
on serotype distribution both in carriage and disease (Weinberger et al., 2011). To 
understand the mechanisms leading to such changes, the study of pneumococcal 
multiple carriage is essential to distinguish between true serotype replacement and 
unmasking of nonvaccine types (Weinberger et al., 2011). Serotyping of multiple 
colonies is the most straightforward approach to detect multiple carriage but is of little 
value due to the high cost and effort needed to achieve a satisfactory sensitivity 
(Huebner et al., 2000). Several initiatives aimed to develop, refine and validate 
alternative methodologies to detect multiple carriage are ongoing (Satzke et al., 2012). 
We have recently studied multiple carriage among children in Portugal and how it has 
been affected by the 7-valent pneumococcal conjugate vaccine (Valente et al., 2012b). 
We used a highly sensitive DNA capsular microarray that is able to detect and quantify 
over 90 serotypes. We observed that the distribution of the most abundant serotypes 
found in multiple carriage was similar to the one observed in single carriage or when 
only a single colony was studied.  
Under the scope of another study of pneumococcal competence pherotypes (Valente 
et al., 2012a), we have retrospectively identified 190 nasopharyngeal samples from 
which 2 pneumococcal serotypes had been detected based on colony morphology. 
These samples were extracted from a collection of 3406 samples obtained through 
cross-sectional studies carried out between 2001 and 2010 among young children. In 
those studies, 1 colony of each morphology was routinely picked from the agar plate. 
We have now reviewed serotype distribution of the isolates present in the samples of 
the 190 co-colonized children and found that close to one-third of the isolates were 
either of serotype 3 (13.4%) or non-typeable (18.2%). The third most abundant type, 
19F, accounted for 6.1% of the isolates. By contrast, the serotype distribution of the 
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entire collection of 3406 samples revealed that, overall, serotype 3 and non-typeable 
strains accounted for significantly fewer isolates: 4.9% and 5.3%, respectively (both P-
values <0.001, χ2 test). Indeed, the 3 most abundant serotypes among the 3406 
samples were 19A (9.0%), 19F (8.2%), and 6A (6.6%). Clearly, non-typeable and 
serotype 3 strains were overrepresented in the collection of co-carried strains selected 
on the basis of colony morphology.  
Experienced laboratory researchers know that serotype 3 and non-typeable isolates 
are easily distinguished on an agar plate from other pneumococci: the former for 
yielding colonies highly mucous, the latter for displaying minute (rough) colonies. Our 
observations may not be surprising but they show and provide a quantitative measure 
on how biased the analysis of serotype distributions can be if multiple carriage is 
detected based on colony morphology. 
Taken together, these observations stress that detection of multiple carriage based on 
colony morphology does not reflect its real epidemiology, not only because it 
underestimates the true prevalence of these events (Valente et al., 2012b), but also 
because it is prone to detect types that display highly distinctive colony morphologies 
resulting in their significant overrepresentation.  
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scope of previous studies. 
Pherotypes of co-colonizing pneumococci 
103 
Summary 
A recent study showed that pneumococcal pherotypes often co-exist in the 
nasopharynx and suggested that the impact of pherotype-mediated fratricide on 
competition is limited. We determined the impact of pherotype (or competence 
stimulating peptide, [CSP]) on pneumococcal nasopharyngeal co-colonization. Of 184 
nasopharyngeal samples yielding two serotypes, 39.9% contained CSP1 only, 12.6% 
CSP2 only and 47.5% had one strain of each pherotype. The observed proportions of 
concordant and discordant pherotypes (52.5% and 47.5%, respectively) were 
compared with the ones estimated (53.8% and 46.2%, respectively) and there were no 
significant differences (p=0.9, Ҳ2 test). Our results support the hypothesis that there is 
a limited role of pherotype in co-colonization. 
 
Introduction 
Streptococcus pneumoniae (the pneumococcus) remains a major cause of morbidity 
and mortality worldwide. Nasopharyngeal colonization, which is asymptomatic, is 
particularly frequent among young children (O'Brien et al., 2009).  
Pneumococci are naturally competent for transformation and horizontal gene transfer 
(HGT) by homologous recombination is considered the main mechanism of evolution of 
this species (Spratt et al., 2001). The nasopharynx, where co-colonization may occur, 
is the privileged niche for such events (Valente et al., 2012). Evidence for in vivo intra- 
and inter-species HGT involving colonizing strains has been described (Barnes et al., 
1995; Hiller et al., 2010).  
In pneumococci, competence is triggered by the competence stimulating peptide 
(CSP), a pheromone that is prone to allelic variation (Havarstein et al., 1995; 
Whatmore et al., 1999). Two dominant pherotypes - CSP1 and CSP2 – have been 
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identified (Pozzi et al., 1996; Ramirez et al., 1997; Whatmore et al., 1999). Each 
pherotype is only recognized by its specific membrane-associated histidine kinase 
ComD receptor that, upon binding of CSP, initiates competence (Havarstein et al., 
1996).  
In recent years, it has been shown that pneumococci can compete in co-cultivation 
through a mechanism called fratricide, in which competent cells can kill their non-
competent sisters (Guiral et al., 2005). During competence an immunity membrane 
protein, ComM, which protects competent cells from their own hydrolases, is produced 
(Havarstein et al., 2006). Bacteria not responding to the external CSP will not express 
ComM and will be killed by their competent siblings (Johnsborg et al., 2008). It has 
been proposed that fratricide could provide access to nutrients, stabilize the 
relationship with the host through immune response, or drive genetic evolution through 
increased gene exchange (Havarstein et al., 2006). 
The role of pherotypes in competition and genetic differentiation remains a matter of 
debate. Specifically, whether or not it restricts recombination in the species is not totally 
clear. Some authors have proposed that the CSP/ComD specificity should imply a 
limited inter-pherotype recombination, resulting in two genetic populations associated 
with the two dominant pherotypes (Carrolo et al., 2009; Claverys & Havarstein, 2007).  
Others argued that the CSP polymorphisms are determinant in driving pneumococcal 
genetic differentiation by acting as a starting point for genetic diversity (Cornejo et al., 
2010).  
A recent study by Vestrheim et. al. has looked at pairs of co-colonizing strains to 
evaluate the impact of pherotype on the co-existence of pneumococci in the 
nasopharynx (Vestrheim et al., 2011). The authors showed that pneumococcal 
pherotypes often co-exist in the nasopharynx and suggested that the impact of 
competence induced fratricide on competition is limited. 
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Considering this seminal and very recent observation, we aimed to determine the 
pherotype of pneumococcal strains from Portuguese co-colonized samples.  
 
Materials and methods 
Bacterial samples. Co-colonizing pneumococcal isolates (n=368) were selected from 
nasopharyngeal samples obtained from children in Lisbon and Oeiras, Portugal, in 
cross-sectional studies conducted in different years, between 2001 and 2010: 2001-
2003, 2006-2007, and 2009-2010, as described before (Mato et al., 2005; Nunes et al., 
2012; Sá-Leão et al., 2009; Simões et al., 2011). Identification of pneumococci was 
done as previously described (Mato et al., 2005). Of 5,809 nasopharyngeal samples 
yielding a pneumococcal positive culture, 184 (3.2%) contained two strains selected on 
the basis of distinct colony morphology and posterior confirmation of distinct capsular 
types. Serotyping was done by the Quellung reaction using commercially available 
pneumococcal antisera (Statens Serum Institute, Copenhagen, Denmark) and/or by 
PCR as described previously (Pai et al., 2006). 
Antimicrobial susceptibility testing. Antimicrobial susceptibility testing was 
performed using the Kirby-Bauer technique, according to the Clinical and Laboratory 
Standards Institute (CLSI) recommendations and definitions (CLSI, 2008) for 
chloramphenicol, erythromycin, clindamycin, tetracycline, and sulfamethoxazole-
trimethoprim (SXT). MIC of penicillin was determined with E-test (AB Biodisk, Solna, 
Sweden) according to the manufacturer’s recommendations and interpreted according 
to CLSI guidelines for oral penicillin. Multidrug resistance was defined as resistance to 
three or more classes of antibiotics.  
 Pherotype assignment. Pherotype assignment was done by detection of CSP1 or 
CSP2 specific gene fragments, using a multiplex PCR described by Carrolo et. al. 
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which generates amplification products of 620 bp and 340 bp, respectively (Carrolo et 
al., 2009).  
Data analysis. Samples in which both pneumococcal strains were of the same 
pherotype were regarded as concordant and samples in which the co-colonizing 
pneumococci belonged to different pherotypes were regarded as discordant. 
Co-colonization of pneumococcal pherotypes was assumed to occur independently and 
the multiplicative rule for independent events [Prob (A and B) = Prob (A) x Prob (B)] 
was used to estimate the distribution of concordant or discordant pherotypes, based on 
the overall distribution of pherotypes in the co-colonized samples, as described by 
Vestrheim et. al. (Vestrheim et al., 2011). Statistical analyses were performed using Ҳ2 
test or Fisher exact test as appropriate.  
 
Results 
Of the 368 pneumococcal isolates all but one isolate were of either CSP1 or CSP2 
corroborating previous studies on the dominance of these pherotypes on the population 
(Carrolo et al., 2009; Cornejo et al., 2010; Ramirez et al., 1997). The single exception 
was obtained for a serotype 38 strain that probably expresses a different pherotype. 
For this reason, one co-colonized sample was excluded from further analyses. Of the 
366 isolates remaining under study, 32 serotypes were represented. Nineteen capsular 
types contained representatives of both pherotypes (Figure 1). Serotypes 5, 7F, 9V, 
11A, 14, 15B/C, 16F, 17F, 21, and 35F contained only representatives of 
CSP1; serotypes 9L/9N and 24F contained only representatives of CSP2 (Figure 1). Of 
all isolates, 63.7% were of pherotype CSP1 (n=233) and 36.3% were of pherotype 
CSP2 (n=133) reflecting the pherotype distribution and the predominance of CSP1 
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described in the literature for clinical isolates (Carrolo et al., 2009; Cornejo et al., 2010; 











Regarding antibiotic resistance, significant associations between pherotype CSP2 and 
resistance to at least one class of antibiotics, multidrug resistance, and individually with 
each of the antibiotics tested (with the exception of chloramphenicol) were observed 
(Table 1). As a substantial proportion (41%) of the CSP2 strains were non-typeable 
(NT) pneumococci, which are frequently drug-resistant (Sá-Leão et al., 2006), the 
analysis was repeated excluding all NT pneumococci. Again, the strength of the 
association between CSP2 and resistance remained significantly higher compared to 
the strength of CSP1: multidrug resistance was 27.9% among CSP1 vs 42.3% among 
CSP2, p=0.02, Ҳ2 test; and resistance to at least one antibiotic was 15.3% among 
CSP1 vs 38.5% among CSP2, p<0.0001, Ҳ2 test). The exclusion of NT pneumococci 
also did not abolish the significant association of resistance to each antibiotic and 
pherotype CSP2. 
Figure 1. Pherotype and serotype distributions. Serotypes with an absolute frequency of 1 (i.e., 
serotypes 8, 9A, 31, 33A, 36, and 38) were grouped as Others. CSP, competence-stimulating 
peptide; NT, nontypeable. 
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Table 1. Association between antimicrobial resistance and pherotype. 
Antimicrobial 
agenta 
CSP1 CSP2 ORb 
(95% CI) 
p 
Resistant Susceptible Resistant Susceptible 
Penicillin G 48 185 68 65 0.25 (0.15;0.40) <0.0001 
Erythromycin 48 185 70 63 0.23 (0.14;0.38) <0.0001 
Clindamycin 44 189 62 71 0.27 (0.16;0.44) <0.0001 
Tetracycline 32 201 69 64 0.15 (0.09;0.25) <0.0001 
Chloramphenicol 3 230 3 130 0.57 (0.09;3.56) 0.38 
SXT 28 205 57 76 0.18 (0.10;0.32) <0.0001 
MDRc 38 195d 70 63d 0.18 (0.11;0.31) <0.0001 
Resistant ≥1e 80 153 83 50 0.32 (0.20;0.50) <0.0001 
 
SXT- sulfamethoxazole-trimethoprim; MDR – multidrug resistant  
aIntermediate and resistant isolates were considered resistant for the analysis. 
bAn OR of > 1, indicates a significant association of CSP1 with resistance to the 
antimicrobial agent, whereas an OR of < 1 indicates a significant association of CSP2 
with resistance to the antimicrobial agent. 
c Multidrug resistance, resistance to three or more classes. The most common profile 
was resistance to penicillin, erythromycin, clindamycin, tetracycline and SXT (2.6% of 
CSP1 strains and 30% of CSP2 strains).  
dIncludes all non-MDR strains 
eResistant to at least one class. 
 
Among the co-colonized samples, 39.9% contained two strains of CSP1, 12.6% 
contained two strains of CSP2, and 47.5% had one sample of each pherotype. When 
the observed and estimated proportions of concordant and discordant pherotypes in 
the co-colonized samples were compared no significant differences were observed 
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(p=0.9, Ҳ2 test) (Table 2), suggesting that co-colonization of pherotypes CSP1 and 
CSP2 occurs independently.  
 
         Table 2. Distribution of pherotypes among co-colonized samples. 
 
 
As the serotype distribution in our samples was characterized by a predominance of 
NT pneumococci (18.0%) and strains of serotype 3 (13.7%) (Figure 1), which could 
potentially bias the results, we repeated the analysis after exclusion of these strains. 
The results indicated that, again, the observed and estimated proportions of 
concordant (55.6% and 56.6%, respectively) and discordant (44.4% and 43.4%, 
respectively) pherotypes were not significantly different (p=0.8, Ҳ2 test). This confirmed 
the results obtained with all samples regarding the independent co-existence of 
pneumococcal pherotypes in the nasopharynx. 
 
Discussion 
The results obtained in our study replicate the observations by Versthreim et. al. 





No. samples Proportion (%) 
CSP1 and CSP1 40.6 73 39.9 
CSP2 and CSP2 13.2 23 12.6 
CSP1 and CSP2 46.2 87 47.5 
Concordant 53.8 96 52.5 
Discordant 46.2 87 47.5 
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In addition, we report a significant association of pherotype CSP2 with antimicrobial 
resistance. As no information on the genetic backgrounds of the strains was obtained, 
the possibility that these findings might result from high clonality between the resistant 
isolates could be raised. In fact, Carrolo et al. observed that pherotype is a clonal 
property and is not randomly dispersed within the pneumococcal population (Carrolo et 
al., 2009). Nevertheless, given the high genetic diversity of the pneumococcal 
population, the high assortment of serotypes in our collection, and the fact that the 
samples were collected in a wide temporal range (2001-2010), clonal diversity within 
each pherotype is expected. 
Of interest, the general association between CSP2 and antibiotic resistance among 
Portuguese isolates from carriage contrasts with the observation that among 
Portuguese isolates from invasive disease an association was described between 
penicillin resistance and CSP1(Carrolo et al., 2009). However, this latter collection was 
obtained in a shorter time period (1999-2002) and before widespread use of conjugate 
vaccines occurred in the country (Aguiar et al., 2008; Sá-Leão et al., 2009; Simões et 
al., 2011) that have resulted in major changes among circulating pneumococci. In 
addition, an asymmetric distribution of circulating lineages among carriage and disease 
is also expected (Sá-Leão et al., 2011) and may also have accounted for these 
contrasting observations.  
Our study (as the one from Verstrheim et al. (Vestrheim et al., 2011)) has some 
limitations. Firstly, samples originated from cross-sectional studies and, therefore, 
duration of carriage was not taken into account (Gray et al., 1980). Whether detection 
of co-colonization results, in general, from a true co-existence event or reflects mostly a 
transitional state remains to be ascertained. Secondly, the relative abundance of the 
co-colonizing strains was not quantified. One can imagine that if the proportion of two 
strains of different pherotypes in the host is very different, competition may be 
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occurring despite their co-existence. Thirdly, we used a convenience sample based on 
the detection of samples where pneumococcal colonies exhibited different 
morphologies. Hence, it is anticipated that we underestimated co-colonization events in 
our collections and that only a subset of it was analyzed. Fourthly, we did not attempt 
to measure whether the isolates had the capacity to become competent and induce 
fratricide. Such approach, could, however, be still inconclusive, as lack of capacity to 
induce competence in vitro does not necessarily imply the strain is unable to undergo 
competence in vivo (Pozzi et al., 1996; Ramirez et al., 1997; Whatmore et al., 1999). 
Still, it is of particular interest that in both studies – ours and the one from Verstrheim et 
al. (Vestrheim et al., 2011) - using collections from different years and geographical 
origins, the same conclusions were reached, suggesting a low impact of CSP-mediated 
competition on pneumococcal co-existence in the nasopharynx. Johnsborg et al. 
(Johnsborg et al., 2008) have previously reported the existence of ComD promiscuity 
between S. pneumoniae and closely-related species, which might allow target bacteria 
to sense a non-cognate CSP resulting in the expression of ComM immunity protein. To 
our best knowledge this cross talk has not been found to occur between pneumococcal 
isolates producing CSP1 or CSP2 and their corresponding ComD1 and ComD2 
proteins. This finding would, however, support the hypothesis that CSP-mediated 
competition has little impact on pneumococcal co-existence.  
In summary, our data support the hypothesis that pherotype-mediated fratricide does 
not seem to be an important mechanism of within-host competition. However, further 
studies of longitudinal design with systematic detection of co-colonization and 
assessment of colonization density are needed to provide further insights on the nature 
of pneumococcal co-colonization.  
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Summary 
Abstract: Bacteriocins are small antimicrobial peptides secreted by bacteria. In 
Streptococcus pneumoniae, a frequent pathobiont inhabiting the human nasopharynx, 
the blp (bacteriocin-like peptides) locus is involved in the regulation and secretion of 
bacteriocins and has been implicated in inter-strain competition in vivo. In this study we 
aimed to evaluate the impact of the blp locus and phenotypes of bacteriocin secretion 
carriage of multiple pneumococcal strains.  
We used a collection of 135 nasopharyngeal samples from individuals carrying two or 
more pneumococcal strains characterized through serotyping, MLST genotyping, and 
assignment of the type of competence stimulating peptide (CSP). The blp locus of all 
isolates was characterized genetically with regards to pheromone type, locus 
functionality and bacteriocin immunity content. Phenotypes of bacteriocin secretion and 
locus activity were assessed through overlay competition assays. Isolates from single 
carriage events (n=298) were also characterized for comparison.  
Genetic analysis of the blp locus revealed that co-colonizing pneumococci present a 
high diversity of blp cassettes, although conservation is essentially maintained among 
related strains. Close to one third of co-colonizing strains showed inhibitory activity 
against a control susceptible strain and over half were inactive. Pneumococci co-
colonized individuals independently of their blp pherotype (p=0.577), locus activity 
(p=0.798) and inhibitory phenotype (p=0.716). Characterization of isolates from single 
carriage revealed no differences when compared to co-colonizing pneumococci. 
Despite clear evidence of blp mediated competition in experimental models, our large 
scale study of natural co-colonizing strains suggests that the blp locus plays a limited 
role in selecting which strains can colonize the nasopharynx simultaneously. 
Importance: Nasopharyngeal colonization with Streptococcus pneumoniae 
(pneumococcus) is important for pneumococcal evolution as it represents an 
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opportunity for horizontal gene transfer when multiple strains co-occur, a phenomenon 
known as co-colonization. Understanding how pneumococcal strains interact within the 
competitive environment of the nasopharynx is of chief importance in the context of 
pneumococcal ecology. In this study we showed that a biological process frequently 
used by bacteria for competition is not determinant in the co-existence of 
pneumococcal strains in the host, contrary to what has been shown in experimental 
models. To our knowledge this is the first time that an unbiased collection has been 




Streptococcus pneumoniae is an important bacterial pathogen causing infectious 
diseases with a high rate of mortality worldwide, particularly among young children, the 
elderly and the immunocompromised (CDC, 2012; CDC, 2014; O'Brien et al., 2009). 
Despite the significant morbidity and mortality attributed to this pathogen, disease is 
rare compared with the rate of asymptomatic nasopharyngeal colonization (Bogaert et 
al., 2004). 
Nasopharyngeal colonization with Streptococcus pneumoniae is prevalent, in particular 
among young children. Co-occurrence of different pneumococcal strains in the human 
nasopharynx, also known as co-colonization or multiple serotype carriage, is also 
frequent, reaching up to 50% of all individuals (Brugger et al., 2010; Turner et al., 2011; 
Valente et al., 2012b; Wyllie et al., 2014). Co-colonization represents an opportunity for 
horizontal gene transfer and is, therefore, an important event for pneumococcal 
evolution (Barnes et al., 1995; Hiller et al., 2010).  
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Little is known about how different pneumococcal strains interact within the 
nasopharynx, but data from longitudinal studies has shown that the pneumococcal 
population colonizing children is in constant turnover. Also, the serotype replacement 
that was observed after the introduction of anti-pneumococcal vaccination suggests 
that a biological mechanism of competition between serotypes was occurring prior to 
vaccination, maintaining the replacing serotypes at a low level in the population 
(Auranen et al., 2009; Lipsitch et al., 2000). Moreover, the fact that the pneumococcus 
natural niche is a dense polymicrobial environment, with limited resources, highlights 
the importance of competitive interactions in its lifestyle (Garcia-Rodriguez & 
Fresnadillo Martinez, 2002) 
A number of molecular mechanisms have been shown to be involved in pneumococcal 
intra-species competition, namely, competence-mediated fratricide and bacteriocin 
production, i. e., production of antimicrobial peptides (Dawid et al., 2007; Guiral et al., 
2005; Havarstein et al., 2006; Reichmann & Hakenbeck, 2000).  
Fratricide occurs during the competent state, in which there is expression of a 
hydrolase, CbpD, and an immunity protein, ComM, which protects competent cells 
against their own lysis.  It is through the induction of CbpD and a number of autolysins 
that immune competent cells kill non-competent (therefore, susceptible) cells sharing 
the same niche. In this way, competent cells not only eliminate direct competitors, but 
also benefit from compounds released by non-competent lysed cells (Havarstein et al., 
2006).  
We and others have previously addressed the impact of the competence stimulating 
peptide (CSP) pherotype on the co-existence of pneumococci, looking at pairs of co-
colonizing strains (Valente et al., 2012a; Vestrheim et al., 2011). Both studies have 
shown that pneumococcal strains can co-exist in colonization independently of their 
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CSP type, suggesting a limited impact of CSP-mediated competition on co-
colonization. 
In S. pneumoniae, bacteriocin production associated with the blp locus has been 
shown to play a role in intraspecies competition in a murine model of colonization 
(Dawid et al., 2007). The blp locus encodes a number of bacteriocins whose secretion 
is controlled by a typical two component regulatory system, constituted by an histidine 
kinase (BlpH) and a response regulator (BlpR), and activated upon binding of the 
signalling peptide BlpC to its cognate BlpH receptor (Dawid et al., 2007; Reichmann & 
Hakenbeck, 2000). Activation of the response regulator BlpR results in the upregulation 
of the entire locus (de Saizieu et al., 2000), including the bacteriocin/immunity region 
(BIR) that encodes the bacteriocins (at least sixteen, several with allelic variability) and 
their cognate co-transcribed immunity proteins (Bogaardt et al., 2015; Son et al., 2011). 
Bacteriocins (and BlpC) are secreted by the ABC transporter BlpAB (Dawid et al., 
2007; de Saizieu et al., 2000; Reichmann & Hakenbeck, 2000). 
Besides the genetic variability of the BIR, at least 5 types of the peptide pheromone 
BlpC have been found, with minor variants among each type (Bogaardt et al., 2015; de 
Saizieu et al., 2000; Reichmann & Hakenbeck, 2000; Son et al., 2011). In addition, a 
disruption in the blpA gene has been shown to render strains with an otherwise intact 
blp locus unable to secrete both the peptide pheromone and the bacteriocin peptides. 
These strains display a cheater phenotype as they are able to recognize exogenous 
BlpC, resulting in the expression of immunity proteins without the cost of peptide 
secretion (Son et al., 2011). The universal conservation of the blp locus in 
pneumococcal genomes and the significant diversity of content suggest that the locus 
provides a competitive advantage during either colonization or transmission.  No 
studies to date have examined whether blp locus activity restricts co-colonization to 
only non-antagonistic interactions. 
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In this study we identified and characterized genotypically and phenotypically a 
collection of co-colonizing pneumococci in order to explore the role of the blp locus and 
bacteriocin secretion on the co-existence of S. pneumoniae in colonization.  The results 
with this strain collection were compared with those from a collection of single carriage 
strains to address possible differences between strains from single and co-colonization 
events. 
 
Materials and methods 
Sample selection and inclusion criteria. Nasopharyngeal samples collected from 
healthy children attending day-care centers in Oeiras and Montemor-o-Novo, Portugal, 
were retrospectively selected from cross-sectional studies conducted between 2001 
and 2010: 2001, 2006-2007 and 2009-2010 (Mato et al., 2005; Nunes et al., 2012; Sá-
Leão et al., 2009; Simões et al., 2011a). Samples were selected with the objective of 
detecting the highest number possible of co-colonization events. Selection was based 
on the previous observation that the serotypes found more frequently in single and 
multiple carriage events are essentially the same (Valente et al., 2012b). In the 
selected years, the serotypes with highest cumulative prevalence were: 3, 6A, 6C, 11A, 
15A, 15B/C, 19A, 19F, 21, 23A, 23B and non-encapsulated pneumococci (NT). All 
samples yielding a pneumococcal positive culture for one of these serotypes in which a 
primary selective plate frozen stock was available (see below) were selected for 
molecular detection of co-colonization, as described below (n=1,415).  
Sample collection, isolation of pneumococci and serotyping. Nasopharyngeal 
samples were collected by pediatric nurses using sterile mini-tip calcium alginate 
swabs and plated on the same day in a primary selective plate of 5% blood trypticase 
soy agar containing 5mg/L gentamicin to select for S. pneumoniae. Plates were 
incubated overnight at 37⁰C under anaerobic conditions with an optochin disk. Swabs 
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were frozen at -80⁰C in 1mL Mueller-Hinton broth with 30% glycerol, with the exception 
of the swabs from 2001-2003 that were discarded. On the second day, pneumococcal 
colonies with different morphologies were picked and plated separately (one colony per 
morphology). The bacterial lawn of the primary selective plate was collected and 
frozen, as described above, in samples collected during or after 2006 and in a subset 
of samples collected during 2001. On the third day, pneumococcal isolates were 
frozen.  
Pneumococcal strains were serotyped by multiplex PCR, as described previously (Brito 
et al., 2003; Pai et al., 2006), http://www.cdc.gov/streplab/pcr.htm]. Strains that could 
not be typed by PCR were serotyped by the Quellung reaction (Sorensen, 1993) using 
commercially available pneumococcal antisera (Statens Serum Institute, Copenhagen, 
Denmark). 
DNA isolation. Total DNA was isolated from 200µL of the primary selective culture 
frozen stock using the High Pure PCR Template Preparation Kit (Roche Diagnostics, 
Mannheim, Germany) according to the manufacturer’s instructions. DNA was eluted in 
100µL milli-Q water (Millipore Corporation, Billerica, MA, USA).  
Detection of co-colonization and capsular typing of the co-colonizing strains. 
Detection of co-colonization was done as previously described (Brugger et al., 2009). 
Briefly, the noncoding region between the pneumolysin gene and the preceding 
hypothetical protein gene was amplified and digested with up to four restriction 
enzymes (Afllll, ApoI, DdeI MseI). Fragments were separated by capillary 
electrophoresis and their sizes were determined. Co-colonization was assumed 
whenever the sum of the size of the digestion fragments was higher than the size of the 
undigested PCR product. 
The putative co-colonized samples were analyzed using the BuG@S SP-CPSv1.4.0 
microarray for molecular serotyping of the co-colonizing strains, as described 
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previously (Brugger et al., 2010). Statistical analysis of the microarray data to 
determine the serotypes present in a sample and their relative abundances was done 
as described in (Newton et al., 2011).  
All serotypes identified by the microarray were confirmed by PCR using as template 
purified DNA of the primary selective growth. 
For the interpretation of the microarray results, a serotype was considered a major 
serotype whenever its relative abundance was ≥70%. Accordingly, a serotype was 
considered a minor serotype whenever its relative abundance was ≤30%. Serotypes 
with relative abundances >30% and <70% were considered co-dominant. 
Isolation of pneumococcal strains from the co-colonized samples. To isolate co-
colonizing pneumococcal strains present in the nasopharyngeal samples 50µL aliquots 
of the primary selective plate frozen stock were prepared, serially diluted and plated in 
5% blood trypticase soy agar containing 5mg/L gentamicin plates to obtain isolated 
colonies. On the following day, individual colonies were picked for amplification of 
serotype-specific capsular genes, using the set of primers described above (Brito et al., 
2003; Pai et al., 2006), [http://www.cdc.gov/streplab/pcr.htm]. The number of colonies 
picked per strain was calculated using the binomial formula described by Huebner et al. 
(Huebner et al., 2000) qn=(1-P), where q=1-[concentration of the serotype], 
P=probability of finding one or more colonies of that serotype and n=number of 
colonies needed to detect the serotype with the assumed probability. For the 
calculations, a probability of 95% was considered and the relative abundances 
determined by the CPS microarray for each serotype in each sample were used. One 
colony positive for each capsular type was subcultured and frozen at -80⁰C in 1mL 
Mueller-Hinton broth with 30% glycerol. For isolation and correct identification of non-
encapsulated pneumococci the method described by Simões et al. was used (Simões 
et al., 2011b).  
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MLST. All co-colonizing strains were genotyped by multi locus sequence typing 
(MLST), performed by amplification of internal fragments of seven housekeeping genes 
(aroE, gdh, gki, recP, spi, xpt and ddl), as described previously (Enright & Spratt, 
1998). Sequencing reactions were conducted at Macrogen, Inc. (Amsterdam, 
Netherlands) and at STAB VIDA. Lda (Caparica, Portugal). Sequence analysis was 
performed either with the Bionumeris software (Applied Maths, Gent, Belgium) or with 
the DNAStar software (DNASTAR, Inc. Madison, WI, USA). Assignment of allele 
numbers and sequence types (ST) was done at the MLST database for S. pneumoniae 
(http://pubmlst.org/spneumoniae/). 
Interpretation of results was performed with the PHYLOViZ platform that uses the 
goeBURST algorithm to determine possible evolutionary relationships between isolates 
(Francisco et al., 2012). Level two was chosen in the goeBURST configuration for 
computing the groups, i.e., strains sharing 5 out of 7 alleles were considered 
genetically related. Clonal complexes (CC) were assigned considering only the 
collection of co-colonizing pneumococci. 
Assignment of pherotype CSP1 or CSP2. Pherotype assignment was done by 
multiplex PCR amplification of specific comC gene fragments, as described previously 
(Carrolo et al., 2009).  
PCR assignment of blpC type. Assignment of the five blpC types described up to now 
was done by amplification of specific blpC gene fragments, using primers designed for 
this study (Table S1). The PCR reactions were done in a 10µl volume with 1x GoTaq 
Flexi Buffer (Promega, Madison, USA), 0.12 mM concentration of dNTPs, 1.0µM 
concentration of each primer, and 1Uµl-1 of GoTaq Flexi DNA Polymerase (Promega, 
Madison, USA). MgCl2 concentration varied according to primer pair (Table S1). DNA 
was obtained from freshly grown bacterial cultures picked with a sterile tip and briefly 
immersed in the PCR reaction mix. Thermocycling was performed with the following 
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conditions: 95⁰C for 5 min; 30 amplification cycles of 95⁰C for 30s, 52-58⁰C (Table S1) 
for 30s and 72⁰C for 45s; and a final extension step at 72ºC for 5 min. PCR analysis 
was done by electrophoresis on 1% Seakem LE agarose gels stained with Ethidium 
Bromide in 1x TAE buffer. 
Assessment of blpA integrity. Detection of the 4 bp repeat insertion was done by 
PCR amplification of a blpA gene fragment containing the region of repeat insertion 
using forward primer 21 described in (Son et al., 2011) and reverse primer with 
sequence AGCCGCTGATGAAATGGGC, followed by digestion with Cac8I (New 
England Biolabs, Ipswich, MA, USA), according to the manufacturer’s instructions. 
Restriction occurs only when the 4 bp repeat is present. 
Samples in which we failed to amplify the region containing the repeat insertion were 
amplified with primers 18 and 19 described in (Son et al., 2011) for amplification of the 
total blpA gene to confirm presence of possible deletions, by comparison of the size of 
the PCR product with that of a control strain with an intact blpA gene. 
RFLP analysis of the bacteriocin/immunity region (BIR) and bacteriocin content 
prediction. RFLP profiles of all isolates were determined as previously described (Son 
et al., 2011). Briefly, PCR products were obtained with primers 1 and 2, purified and 
digested with AseI (New England Biolabs, Ipswich, MA, USA), according to the 
manufacturer’s instructions. Digestion products were analyzed by capillary 
electrophoresis and isolates with identical restriction patterns were assigned to the 
same group.  
BIR content was predicted by comparison of RFLP profiles with those of sequenced 
strains available at GenBank, using either VectorNTI® or CLC Genomics softwares. 
Overlay assays with reporter strains of known BIR contents (Table 1) were performed 




Overlay assays. Inhibition and activity overlay assays were performed as described 
elsewhere (Son et al., 2011) and using the reporter strains listed in Table 1. Briefly, 
strains were grown overnight on 5% blood trypticase soy agar (TSA) plates, colonies 
were collected with a tip and inserted into TSA plates supplemented with ≈ 4,700U 
catalase, followed by a 6h incubation at 37ºC in 5% CO2. Overlay reporter strains were 
grown at 37ºC in Todd Hewitt broth supplemented with yeast extract (THY) to an OD620 
Table 1. Reporter strains for characterization of the blp locus  
Strain 
designation 
Strain characteristics Reference 
P537 
Serotype 6A strain with deletion of 
blpRHCBA-BIR. Susceptible to all 
bacteriocins secretion.  
Reporter of inhibitory activity 
 (Son et al., 2011) 
PSD121 
R6 background; insertion of a type P164 blp 
locus, with blpC deletion and lac-Z reporter 
under control of the BIR promoter.  
Type P164 BlpC/BlpH reporter 
(Kochan & Dawid, 2013) 
PSD101 
R6 background; insertion of a type R6 blp 
locus, with blpC deletion and lac-Z reporter 
under control of the BIR promoter.  
Type R6 BlpC/BlpH reporter 
(Pinchas et al., 2015)    
PMP105 
R6 background; insertion of a type 6A blp 
locus, with blpC deletion and lac-Z reporter 
under control of the BIR promoter.  
Type 6A BlpC/BlpH reporter 
(Pinchas et al., 2015)    
PMP105 
R6 background; insertion of a type T4 blp 
locus, with blpC deletion and lac-Z reporter 
under control of the BIR promoter.  
Type T4 BlpC/BlpH reporter 
(Pinchas et al., 2015)    
P1 
Serotype 6A, BIR with MNO, BlpC6A. 
Control for MNO BIR content 
(Kim & Weiser, 1998) 
P4 
Serotype 6B, BIR with QMNO, BlpCP164.  
Control for QMNO BIR content 
(Kim & Weiser, 1998) 
P132 
Serotype 29, BIR with K, type 3 BlpC6A.   
Control for K BIR content   
(Son et al., 2011) 
P133 
Serotype 6A, BIR with IJK MNO, BlpCR6.   
Control for IJK MNO BIR content 
(Son et al., 2011) 
P140 
Serotype 35B, BIR with IJK, BlpCR6.   
Control for IJK BIR content   
(Son et al., 2011) 
P155 
Reference for sequencing analysis of the 
blpC gene of strains with blpCP155 type.  
(Son et al., 2011) 
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of 0.5. Two hundred microliters of culture were added to a 15 ml conical tube 
containing 5ml of THY, 3mL of molten TSA, ≈ 4,700U catalase, and 50µl of X-Gal at 
40mg/ml (for signaling overlays only). The mixture was applied over the TSA plates 
containing the pre-grown isolates, followed by an overnight incubation at 37ºC in 5% 
CO2. Plates were inspected for halos of growth inhibition (inhibition overlays) or β-
galactosidase activity (signaling overlays). Each overlay assay was performed twice on 
two different days, with at least two technical replicates in every assay.  
Data analysis. As our collection of co-colonized samples included a number of 
samples with three pneumococcal strains, for the data analysis dual interactions of 
pneumococcal strains were considered: samples with two strains accounted for one 
interaction and samples with three strains accounted for three interactions.  
For each comparison, interactions of strains with the same genotypic and/or phenotypic 
characteristic were regarded as concordant and interactions of strains with different 
genotypic and/or phenotypic characteristic were regarded as discordant. 
The frequency of inhibitory activity, serotypes, CSP, BlpC and BlpA types were 
compared between strains found in co-colonization and strains found in single 
colonization samples. Frequency data was organized in contingency tables where rows 
were defined by different types and columns by single and co-colonization sets of 
strains. To detect statistically significant differences, 5000 random contingency tables 
were generated by randomly permuting the strain’s row and column label. This process 
generates tables with constant row and column totals that are consistent with the null 
hypothesis that row distribution is independent of column membership. A quantile q for 
each individual frequency in the contingency table was computed as the fraction of 
random tables with a lower frequency. If q>0.5, then the corresponding two-tail p-value 
is 2(1-q), otherwise the p-value is 2q. The deviation of the complete contingency table 
from the null hypothesis was also evaluated through a Fisher’s Exact Test. A similar 
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analysis was performed to compare the sets of strains found in co-colonizing samples 
classified as minor, co-dominant or major, according to their relative abundance.  
The frequency with which pairs of serotypes (or of CSP, BlpC and BlpA types) appear 
together in co-colonizing samples was also compared with a null hypothesis where 
strains mix randomly. The frequency distribution under the null hypothesis was 
estimated through 5000 random assignments of strains to the samples with co-
colonization events. This random assignment maintained the number of different 
strains detected in each sample. Additionally, each sample had to contain at least one 
strain from the set of serotypes used initially to select the samples included in this 
study (3, 6A, 6C, 11A/D, 15A, 15B/C, 19A, 19F, 21, 23A, 23B, NT). A quantile q for 
each possible pair type frequency was computed as the fraction of randomizations with 
a lower frequency. If q>0.5, then the corresponding two-tail p-value is 2(1-q), otherwise 
the p-value is 2q. A similar analysis was performed to compare the pair type frequency 
among samples with major/minor versus co-dominant co-colonization events. 
Frequency deviations were considered significant when p-values<0.05.  
 
Results 
Detection of co-colonization and isolation of pneumococcal strains from co-
colonized samples. Out of the 1,415 samples included in the study, 362 samples 
were excluded after the plyNCR amplification, due to insufficient pneumococcal DNA in 
the sample. The combination of the plyNCR-RFLP with the capsular microarray 
indicated the presence of two or more pneumococcal strains in 162 out of 1,053 
samples (15.4%). Serotypes detected by the microarray were confirmed by PCR. 
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The capsular microarray identified 358 putative pneumococcal strains in the 162 co-
colonized samples. By serial dilutions of the total bacterial growth, colony PCR 
serotyping, and confirmation of the colonies obtained as bona fide pneumococci we 
obtained 135 co-colonized samples with more than one pneumococcal strain isolated 
(further details in Figure S1). Of these, 120 samples contained two pneumococcal 
strains (88.9%) and 15 samples contained three pneumococcal strains (11.1%). This 
collection was used in the following analyses. 
S. pneumoniae strains co-colonizing individuals are highly diverse and co-exist 
independently of the capsular type and genotype. The total collection of co-
colonized samples (n=135) contained 285 pneumococcal strains and was highly 
diverse. Thirty-six capsular types were found and MLST genotyping clustered strains in 
19 clonal complexes (CC, CC1-CC19) and 36 singletons (S, S1-S36) (Figure 1).  
A permutation analysis to test if serotypes or genotypes were found in co-colonized 
carriers at frequencies different than the ones expected by chance showed that 
serotypes 3 and NT were found in co-colonization at a lower frequency than expected 
(p<0.0001 for both serotypes) while serotype 15B/C was found in co-colonization 
events at a higher frequency than expected (p=0.0342). No statistical significance was 
reached when the analysis was repeated for genotypes.  
Due to the high number of serotypes present in the collection, the frequency in which 
specific pairs of serotypes co-occurred was low, although we were able to find positive 
associations between pairs of serotypes (i.e., pairs that co-occurred at a significantly 
higher frequency than the one expected based on the distribution of those serotypes in 
the population: NT-21 (p=0.027), 6C-19A (p=0.046), 16F-21 (p=0.003), 23F-19F 











Figure 1. Genetic diversity and characteristics of the blp locus of co-colonizing pneumococci. 
Only clonal complexes are represented. RFLP profiles mached to genome sequenced strains 
(GenBank designations): 1 (GA13723), 2 (AP200), 3 (GA13856), 4 (GA54354), 5 (20703335), 7 
(GA47439), 9 (670-6B), 10 (OXO141), 11 (GA17971), 14 (46518), 18 (SP14-BS69), and 19 
(GA47502). *RFLP profiles with no match in GenBank. 
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Accordingly, several positive associations between specific genotypes were also found: 
CC7-CC1 (p=0.03), CC7-S19 (p=0.006), CC7-S14 (p=0.04), CC4-S12 (p=0.002), CC4-
S27 (p=0.003), CC5-CC19 (p=0.03), and S12-S27 (p=0.01). Of note, MLST analysis 
revealed 24 novel STs, 10 of which were originated by the presence of new alleles. 
The remaining 14 were the result of novel allele combinations. Among the latter, for 
three STs (ST9160, ST9162 and ST9164) the allele separating the novel ST from its 
SLV was shared with its co-colonizing strain, suggesting that within host recombination 
might have occurred with co-colonizing strain (Table 2). 
 
a Closest ST found in the MLST database (http://spneumoniae.mlst.net/). NP, 
nasopharyngeal; ST, sequence type; CSP, competence stimulating peptide. 
CSP assignment of all strains showed that 35.2% of the interactions occurring in the 
135 co-colonized samples were between two strains of CSP1, 10.9% were between 
two strains of CSP2, and 51.5% were between strains of different pherotypes (CSP1, 
CSP2, and other type present in strains from serotype 38). When the frequency in 
which CSP types appear together in co-colonization was compared with the frequency 
Table 2. Evidence for putative horizontal gene transfer in vivo in NP samples 
characterized in this study. 
NP sample ST aroE gdh gki recP spi xpt ddl CSP 
Sample 8043          
8043-19A 9160 1 60 9 8 6 3 29 CSP1 
8043-6C 395 1 5 7 12 17 1 14 CSP2 
8043-31 1766 1 5 29 1 46 14 18 CSP2 
Closest STa 1151 7 60 9 8 6 3 29 - 
Sample 8058          
8058-3 9162 2 15 2 10 6 1 22 CSP1 
8058-23A 9163 2 8 9 9 6 4 6 CSP1 
Closest STa (3) 180 7 15 2 10 6 1 22 - 
Closest STa (23A) 190 8 8 9 9 6 4 6 - 
Sample 8169          
8169-NT 9164 7 8 4 18 15 4 31 CSP2 
8169-6C 1150 7 25 8 6 25 6 8 CSP1 
Closest STa 5516 2 8 4 18 15 4 31 - 
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estimated under the hypothesis that strains mix randomly, the results suggest a 
tendency for co-colonization with strains of different CSP types, although with low 
robustness (p=0.048).  
 Despite the positive associations found at the serotype and genotype levels, the large 
diversity of our collection seems to suggest that pneumococcal strains co-colonize the 
human nasopharynx independently of their capsule, genetic background and CSP type. 
Genetic characterization of the blp locus of co-colonizing pneumococci reveals 
high diversity of blp cassettes. The genetic characterization of the blp locus of the 
co-colonizing strains was focused on the assignment of the blpC type and in the 
assessment of the blpA integrity (presented later in the Results section), and in the 
RFLP analysis of the BIR. The results are summarized in Figure 1. 
Thirty-six RFLP profiles were identified in the co-colonized collection, from which 16 
could be assigned to known BIR sequences available in GenBank and accounted for 
71.2% (n=203) of the strains. The remaining 23 profiles corresponded to not yet 
described BIR regions and accounted for 25.3% (n=72) of the strains. In ten strains 
(3.5%) we were not able to amplify the BIR region, despite several attempts. Of note, 
some BIR profiles, such as profiles 7 and 11, were detected in many clonal complexes 
(CC). Other profiles, highly prevalent as well, were restricted to a single CC, such as 
profiles 10 and 8, associated with CC5 and CC2, respectively. Our BIR predictions 
indicated that the number of bacteriocin peptides present in the co-colonizing strains 
varied between 2 and 6. Interestingly, profiles predicted to contain the highest number 
of bacteriocin peptides (profiles 7 and 11) were associated mostly with strains with a 
disrupted blpA, i.e., cheater phenotype. 
In agreement with previous studies, within each CC, the BIR region displayed a higher 
level of diversity, when compared to blpA and blpC. Nevertheless, taking into account 
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the 3 regions of the locus, our results show that there is conservation of the locus 
among related strains. 
Pheromone peptides BlpC are not equally distributed in the population and do 
not restrict co-colonization. Co-existence of strains secreting different BlpC peptides 
implies that the strain at higher cell density would activate their blp locus earlier and be 
at a competitive advantage. To assess if the type of BlpC could prevent or facilitate co-
existence of pneumococci in the host we determined the blpC allelle of the 285 co-
colonizing strains. The results showed that 36.8% of the strains were of type blpCT4, 
22.5% of type blpCP164, 22.1% of type blpC6A, 16.5% of type blpCR6, and 2.1% of type 
blpCP155. These results suggest that blpC types are not equally distributed in the 
pneumococcal population, with blpCT4 being significantly more prevalent and blpCP155 











Figure 2. Distribution of blpC types in the co-colonization strains. Asterisks 
indicate statistically significant differences. Error bars represent standard error. 
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To confirm the result obtained by PCR, signaling overlay assays were performed for all 
strains using reporter strains for each BlpC type (Table 1). The BlpC type was 
confirmed in all strains in which it was possible to confirm locus activity, as indicated by 
the β-galactosidase activity in the assays (n=59). However, there was a significant 
proportion of strains in which we were not able to confirm phenotypically the secretion 
of the specific BlpC type (79%).  
Since no reporter strain was available for blpCP155, all strains in which this blpC type 
was detected by PCR were confirmed to be of type P155 by sequencing of the PCR 
product and comparison with that of the reference strain P155. Of note, this blpC type 
was associated exclusively with non-encapsulated pneumococci. 
Looking at the sets of co-colonization samples, 40.6% of the dual interactions were 
between strains of the same BlpC type, while 59.4% were between strains of different 
BlpC types. When the frequency in which BlpC types appear together in co-
colonization was compared with the frequency estimated under the hypothesis that 
strains mix randomly no significant difference was found (p=0.577). The same analysis 
was performed considering only pairs of strains in which secretion of BlpC was 
confirmed phenotypically through overlay assays in one of the strains and the results 
were the same (p=0.798). 
Of note, a permutation analysis showed that strains of blpC6A are found with strains of 
blpCT4 at a higher frequency than the one estimated based on the frequency of these 
two types in the collection (p=0.04). 
High prevalence of strains with disrupted blpA gene co-colonizing in nature. 
Disruption of the blpA transporter gene has been previously associated to a cheater, 
i.e., non-inhibitory immune-only, phenotype (Son et al., 2011). Analysis the blpA gene 
confirmed a disruption in the gene in 155 out of 285 strains (54.4%). Of these, 151 
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strains contained the 4 bp repeat insertion described by Son et al. (Son et al., 2011) 
and 4 strains presented a larger deletion, as confirmed by the amplification of the total 
blpA gene.  
The presence of these frameshift-causing insertions and deletions was an explanation 
for the high proportion of strains with a non-inducible locus in the signaling overlay 
assays, as 69% of the non-inducible strains were in fact cheaters. blpA disruption was 
mainly associated with strains of type blpCR6 and blpCT4 (p=0.0001 for both, Fisher’s 
exact test) (Figure 2). 
In the sets of co-colonized samples, 27.9% of dual interactions occurred between two 
cheater strains, 20.6% between strains with an intact blpA gene (non-cheater), and 
51.5% of interactions occurred between a cheater and a non-cheater strain. 
Comparison of the estimated and observed proportions of events involving strains with 
same or different blpA status (intact or disrupted) did not show a significant difference, 
suggesting that the cheater phenotype alone does not restrict co-colonization of 
pneumococci (p=0.713). 
Phenotypes of bacteriocin secretion do not restrict co-colonization. To determine 
the phenotype of bacteriocin secretion, i. e., the inhibitory activity of the pneumococcal 
strains, overlay assays with a susceptible reporter strain P537 (Δblp) were performed. 
Eighty-four out of 285 (29.5%) co-colonizing strains displayed inhibitory activity against 
P537. Of these, 21 strains (25%) had a disrupted blpA gene, suggesting a non-blp 
mediated inhibition. The remaining 63 strains had an intact blpA gene. Of these, we 
were able to confirm corresponding BlpC pheromone secretion with the signaling 
overlays in 63.1% (n=53) of inhibitory strains and failed to do so in 11.9% (n=10). 
Among the strains that did not display inhibitory activity (n=201), 67% were cheaters 
and 30% did not secrete pheromone in the signaling overlays, despite an apparently 
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intact blpA gene. Six strains had a functional locus confirmed by the signaling overlays 
but still failed to inhibit the susceptible strain P537. The BIR prediction of these six 
strains revealed the presence of several bacteriocin peptides, including blpI, blpJ, blpK, 
blpM, and blpN, which have been shown to function as inhibitory peptides (Dawid et al., 
2007; Lux et al., 2007; Son et al., 2011). Of note, none of these strains were able to 
inhibit any of the control strains with known BIR content (Table 1) in inhibition overlay 
assays, contrary to what would be expected based on genetic content of the BIR, blpA 
and blpC.  
In the sets of co-colonized samples, co-existence of strains that displayed an inhibitory 
phenotype with was not different from the expected by chance, suggesting that an 
inhibitory phenotype alone does not prevent co-colonization (p=0.715). 
Considering this result, we performed an in silico prediction of the outcome of the 
interaction of each pair of strains in every sample, taking into account the genetic 
content of the BIR, the integrity of the blpA transporter gene and the type of signaling 
peptide BlpC secreted. Our prediction resulted in 50 outcomes of inhibition (30.3%) and 
115 outcomes of no inhibition (69.7%). Comparison of the estimated and observed 
proportions of outcomes of inhibition and no inhibition did not show a significant 
difference (p=0.274).  
The results obtained with the genotypic and phenotypic approaches suggest that the 
blp locus alone does not seem to prevent the co-existence of pneumococci in the host. 
Phenotypes of bacteriocin secretion are the same in strains isolated from single 
and co-colonization events. In order to assess whether strains found in single and 
co-colonization events would display different genotypic and/or phenotypic blp 
characteristics, we selected for comparison a subset (n=298) of the initial collection of 
1,053 nasopharyngeal samples screened for carriage of multiple serotypes in which 
only one strain was detected. This selection was performed randomly but maintaining a 
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matched number of samples from each year between both collections. The 
characteristics of this collection are summarized in Table S2.  
Overall, the prevalence of each blpC type was similar in the two collections, as well as 
the distribution of inducible, non-inducible and cheater strains within each blpC type 












The proportion of strains isolated from single carriage that displayed an inhibitory 
phenotype against the susceptible strain P537 was comparable to the one observed in 
the co-colonization strains (26.8% and 29.5%, respectively). The same was observed 
for the proportion of strains with a disrupted blpA gene (53.7% and 54.4%, 
respectively) and the proportion of strains with evidence of pheromone secretion 
revealed by the β-galactosidase activity in the signaling overlays (60.9% and 43.8%, 
respectively) (Figure 3B). 
Figure 3. Characterization of the blp locus of the strains isolated from single carriage 
events. (A) Distribution of blpC types in the co-colonization strains. Asterisk indicates statistically 
significant differences. (B) Comparison of the single and co-colonized collections regarding 
proportions of strains with inhibitory phenotype, cheater genotype and locus inducibility. Error 
bars represent standard error. 
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Comparison of the results of the two collections suggests that pneumococci that are 
found in single and co-colonization events seem to possess the same phenotypes of 
bacteriocin secretion, corroborating that, with the approach used in this study, the blp 
locus seems to have little impact on the co-existence of strains in the nasopharynx. 
 
Discussion 
In this study we have identified a collection of co-colonized nasopharyngeal samples to 
assess the impact of the blp locus and bacteriocin secretion on the co-existence of 
pneumococci in the host. We have also identified a matched collection of pneumococci 
isolated from single carriage events that was used as a reference to evaluate possible 
differences between strains in single and co-colonization. 
Characterization of the co-colonization strains at the level of serotype and genotype 
enabled us to identify positive associations between specific capsular types and 
genotypes, although no straightforward observations could be found to explain those 
associations. At the capsular level, we explored properties shown to be dependent on 
the capsular type,  such as the polysaccharide structure, and, by association, the 
fitness cost of capsule production (Hathaway et al., 2012; Weinberger et al., 2009), and 
the surface charge of the capsular type (Li et al., 2013). All these properties have been 
shown to predict to the prevalence of the serotypes. On one hand it was proposed that 
serotypes with capsule structures with more carbon in their polysaccharide repeat unit 
would require more energy for capsule production and would have smaller capsules. 
Therefore, these serotypes would be less resistant to phagocytosis and clearance, 
which could explain their low prevalence (Hathaway et al., 2012; Weinberger et al., 
2009). On the other hand, the surface charge was also proposed to explain the 
prevalence of serotypes, since capsules more negatively charged were shown to repel 
host immune cells that contribute to clearance, such as neutrophils and macrophages 
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(Li et al., 2013). We assessed all these properties in our collection of co-colonized 
samples: the number of carbon molecules per polysaccharide repeat unit was 
determined based on the published capsule structures (Bentley et al., 2006) and the 
surface charge was inferred from the data published by Li et al. (Li et al., 2013).  Our 
prevalence results are in agreement with the proposed hypothesis but none of the 
explored properties could be used to predict capsular interactions (data not shown). 
The genetic characterization of the blp-locus of the co-colonizing strains allowed us to 
show a very large diversity in this locus, originated from the diversity in the blpC, blpA 
and BIR region, supporting observations from other studies (Bogaardt et al., 2015; 
Dawid et al., 2007; de Saizieu et al., 2000; Lux et al., 2007; Son et al., 2011). 
Notwithstanding, MLST genotyping of the strains enabled us to show a fairly high level 
of conservation of the blp-locus among closely-related strains.  
Overall our genotypic and phenotypic characterization of the blp-locus of co-colonizing 
pneumococci seems to suggest that the phenotypes of bacteriocin secretion do not 
have an impact in the co-existence of pneumococci in the nasopharynx, an observation 
that was supported by the lack of differences in the results obtained in the 
characterization of the single carriage isolates. Given the large diversity in this locus, it 
is not surprising that the effect of blp-mediated competition on co-colonization is not as 
straightforward as might be expected and several aspects must be taken into account. 
First, the high diversity of BlpH receptors, that can be higher than the diversity of BlpC 
peptides due to the existence of naturally occurring chimeras for the blpH6A gene, as 
described by Pinchas et al. (Pinchas et al., 2015), and may affect the likelihood of 
cross stimulation between co-colonizing pairs. These authors have shown that these 
BlpH variants have different specificities for cognate and non-cognate BlpC peptides, 
which can have an effect in the race for blp locus activation. Pinchas et al. have also 
shown some level of specificity of BlpHT4 to the non-cognate signalling peptide BlpC6A 
and have proposed that this ability to respond to pheromone secreted by other strains 
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might act as a compensation for the fact that most of BlpHT4 have a disrupted blpA. Our 
colonization data further supports this hypothesis, as we confirmed that BlpCT4 strains 
are the most prevalent BlpC type and are mostly cheaters. Furthermore, we have found 
a positive association that was observed between strains of blpC6A and blpCT4 types 
that might be explained by the promiscuity of the BlpH receptor.  Second, the large 
array of bacteriocins and immunity proteins that can be present in a strain, and the fact 
that the pneumococcal natural niche is such an hostile polymicrobial environment, raise 
the hypothesis that this competition mechanism might be used for mediating the 
interaction not only with bacteria from the same species, but also with other inhabitants 
of the nasopharynx. In fact, Lux et al. (Lux et al., 2007) have demonstrated the 
inhibitory activity of pneumococci against bacteria of different species. Finally, the 
natural and highly frequent occurrence of strains that display a cheater phenotype also 
contributes to the complexity of this competition mechanism. The reason why these 
cheater strains are so highly prevalent remains to be addressed and the advantage of 
displaying this phenotype is not completely clear. On one hand, these strains avoid the 
fitness-cost of bacteriocin secretion while they are still able to express immunity 
proteins. On the other hand they become at risk of elimination upon the encounter of a 
strain secreting a different BlpC type. Recently Kjos et al. (Kjos et al., 2015) have 
suggested a connection between the com and blp systems, demonstrating that a strain 
with a disrupted blpA (D39) was able to activate its blp locus using comAB as a 
replacement transport system when competence is activated. We have performed 
signalling overlays in close to 600 strains, from which over half had a disrupted blpA 
gene, and we were never able to see locus activation in a strain with blpA disruption. 
Nevertheless, we have repeated the analysis performed in this study considering that 
all strains would be able to activate the blp locus and secrete bacteriocins and the 
conclusion that bacteriocin secretion does not restrict co-colonization was maintained. 
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Our study has some limitations. First, we did not sequence individual genes in the 
locus. Given this, the strains that had apparently intact blpA genes but lacked 
pheromone secretion may have been inactive due to uncharacterized mutations in 
blpA, blpH or blpR.  Another explanation could be a lack of sensitivity of the assay or 
particular conditions of locus activation in those strains. In addition, the few non-
inhibitory strains with intact pheromone secretion may have harbored mutations in their 
bacteriocin genes that would not be detected with the RFLP analysis. Second, the 
cross-sectional nature of our study prevented us from measuring the effect of blp-
mediated competition on the duration of carriage. Also, we did not measure the 
pneumococcal load in the samples and it is possible that the effects of competition 
might be reflected at the level of carriage density. Even so, we measured the relative 
proportion of each strain in the samples and could not establish a correlation between 
phenotypes of bacteriocin secretion and strain density. The third limitation is the fact 
that we did not measure the ability of the strains to activate the blp locus in vivo, which 
would be a requirement for this mechanism to have an impact on co-colonization. 
Nevertheless, Dawid et al. (Dawid et al., 2007) have used wild type and bacteriocin-
deleted mutants in dual colonization experiments and have observed that the 
production of bacteriocins by the wild type strains was able to reduce colonization with 
the deleted mutants. Also, Son et al. (Son et al., 2011) have also shown a competitive 
advantage of baceriocin producers vs sensitive, compared with bacteriocin producers 
vs immune strains. These results showed that the locus is active in vivo and is able to 
play a role in the polymicrobial environment of the nasopharynx. 
Our study also has significant strengths. We have used a very well characterized, 
natural collection of co- and singly colonized samples identified through the use of 
highly sensitive molecular methods, which enabled us to obtain an unbiased and highly 
diverse collection of both single and co-colonizing pneumococcal strains. To our 
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knowledge, this is the first time that co-colonized samples have been used to measure 
the impact of blp-bacteriocin production on competition in the nasopharynx.  
Although we have not seen an effect of blp-mediated competition on co-colonization, 
the fact that this locus is present in all pneumococci and has been maintained by 
evolution (Bogaardt et al., 2015) suggests an important function, which is supported by 
the results obtained in competition experiments showing that the locus is active in vivo 
(Dawid et al., 2007). Exactly what this function is and at which level it is exerted 
remains to be fully elucidated. It could be important under specific conditions (e.g., 
nutrient limitation) or during the establishment of a strain during colonization. Also, 
studies with a longitudinal design would help to determine whether blp-mediated 
competition might be acting at the level of carriage duration or density. 
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CSP type blpC types blpA  
3 (13) CSP1 blpCR6, blpC6A, blpCT4 Disrupted/Intact 
6A (23) CSP1, CSP2 blpCP164, blpC6A, blpCT4 Disrupted/Intact 
6C (30) CSP1, CSP2 blpCP164, blpCR6, blpC6A Disrupted/Intact 
11A/D (24) CSP1 blpCP164, blpC6A Disrupted/Intact 
15A (17) CSP1 blpCT4 Disrupted/Intact 
15B/C (28) CSP1 blpCR6, blpCT4 Disrupted 
19A (61) CSP1, CSP2 blpC6A, blpCT4 Disrupted/Intact 
19F (35) CSP1, CSP2 blpCP164, blpCR6, blpC6A Disrupted/Intact 
21 (14) CSP1 blpCP164, blpCT4 Disrupted 
23A (15) CSP1 blpCR6, blpC6A Disrupted/Intact 
23B (25) CSP1 blpCP164, blpCT4 Disrupted/Intact 
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Figure S1. Summary of results of the strategy used for isolation of pneumococcal 












Pneumococcal co-colonization of the nasopharynx has been recognized for several 
years but its dynamics, prevalence and effects on pneumococcal population have 
remained largely unknown. The work developed under the scope of this thesis enabled 
us to determine the prevalence of co-colonization among Portuguese children and to 
evaluate the impact of the introduction of pneumococcal conjugate vaccines on its 
dynamics. Moreover, using an epidemiological approach, we have explored molecular 
mechanisms that could influence co-colonization, focusing on bacterial-related 
properties such as the capsule, the genetic background, competence mediated-
fratricide, and bacteriocin secretion. 
The results presented in Chapter II show that vaccination with PCV7 resulted in a 
lower co-colonization rate due to an asymmetric distribution between NVTs found in 
single and co-colonized samples. We propose that this asymmetric distribution is 
attributable to the fact that some NVTs prevalent in the PCV7 era might be more 
competitive than others, hampering their co-existence in the same niche. This result 
may have important implications since a decrease in co-colonization events is 
expected to translate in decreased opportunities for horizontal gene transfer, hindering 
pneumococcal evolution events such as acquisition of antibiotic resistance 
determinants or capsular switch, which might represent a novel potential benefit of 
conjugate vaccines.  
As a follow up of the study presented in Chapter II, the study presented in Chapter III 
was conducted. This study had a similar design to allow comparisons but was 
conducted after the introduction of PCV13 and was aimed at evaluating the effect of 
this vaccine on pneumococcal co-colonization. Despite some differences in the 
methodological approaches the conclusions of both studies were similar. In Chapter III 
we also showed that PCV13 vaccinated children are less co-colonized than non-
vaccinated children from the same era. As in the PCV7 era, we observe an asymmetric 
redistribution of NVTs in single and co-colonization events. This observation supports 
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our previous hypothesis of different competitive abilities among NVT serotypes, which 
prevents their co-existence. 
The results presented in Chapter III show also that PCV13 serotypes are still prevalent 
in a population with no universal but very high vaccine coverage, mainly among non-
vaccinated children. While in vaccinated children PCV13 serotypes are infrequent and 
found mainly as a minor serotype, in non-vaccinated children these serotypes are still 
highly prevalent and in high abundance. 
Finally, the results of Chapter III show also a very high prevalence of non-
encapsulated pneumococci and Streptococcus spp., particularly among vaccinated 
children. Whether it is an effect of the use of conjugate vaccines and which role these 
species can play in the nasopharyngeal ecosystem and in the evolution of 
pneumococci are questions that remain to be addressed. 
Still in the context of assessing the prevalence of co-colonization, in Chapter IV it is 
shown that the use of methodologies based on colony morphology to detect co-
colonization events results in an overrepresentation of serotypes that display very 
distinctive colony morphologies, such as serotype 3 and non-encapsulated 
pneumococci, introducing a significant bias in the estimated serotype distribution of the 
pneumococcal population.  
In Chapters V and VI we explored molecular mechanisms that could potentially have 
an impact on the co-existence of pneumococci in the nasopharynx. 
In Chapter V a study focused on the impact of pherotype (or competence stimulating 
peptide) on pneumococcal nasopharyngeal co-colonization was conducted. Despite the 
bias that might be introduced in the collection by the fact that co-colonized samples 
were identified based on colony morphology, this study showed that pneumococcal 
pherotypes co-colonize individuals independently, suggesting that pherotype-mediated 
fratricide is not an important mechanism of within-host competition. Our results are in 
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agreement with a previous study of similar design but in a different setting (Vestrheim 
et al., 2011), which supports our findings. Also, the same type of analysis was 
performed in the collection presented in Chapter VI, obtained through the use of highly 
sensitive methods for systematic detection of co-colonization, and the results were the 
same. 
In Chapter VI we explored the role of the blp locus and bacteriocin secretion as a 
competition mechanism that could potentially influence the co-existence of 
pneumococci in the host. As already mentioned, we have used a collection of co-
colonized samples identified through the use of molecular methods that enabled us the 
systematic detection of co-colonization events. As such, we have obtained a highly 
diverse collection of co-colonizing isolates that allowed us to explore the possible 
existence of associations at the level of serotype and genotype. In fact, we were able to 
find positive associations between specific capsular types and genotypes, although 
none of the explored properties could explain such associations. 
As for the impact of the blp locus on co-colonization, we show in Chapter VI that co-
colonizing pneumococci present high genetic diversity at the level of this locus and 
display several different phenotypes of bacteriocin secretion and immunity. We show 
also that pneumococcal strains co-colonize individuals independently of the genetic 
content of their blp-locus and independently of their phenotypes of bacteriocin 
secretion. In addition, we demonstrate that pneumococci identified in single carriage 
events are similar to co-colonizing pneumococci regarding the genetic characterization 
of the blp locus and the phenotypes of bacteriocin secretion. 
The work developed under the scope of this thesis gives an important contribution to 
the available knowledge on co-colonization. Nevertheless, important questions remain 
to be addressed. 
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The first question is related to the major limitation of our studies. Because we have 
used an epidemiological approach based on cross-sectional studies, we were not able 
to measure if the bacterial properties and molecular mechanisms that we have 
explored to explain co-colonization somehow might be affecting the density and 
duration of carriage events or the carriage of a specific strain that could be at a 
disadvantage. Several epidemiological and experimental observations point to the fact 
that this might be a possibility, as presented in Chapter I. Studies with a longitudinal 
design are necessary to determine whether the explored properties and competition 
mechanisms might be acting at the level of carriage duration or density. Also, we have 
not addressed if the two competition mechanisms explored in the context of this thesis 
(pherotype-mediated fratricide and bacteriocin secretion) are active and relevant in an 
in vivo context. 
The second question concerns the possible effect of the microbiota on pneumococcal 
intra-specific interactions, which was not taken into consideration in these studies.  The 
nasopharynx, however, is a complex polymicrobial environment and there is increasing 
evidence that the pneumococcus is involved in multispecies biofilms (Hall-Stoodley et 
al., 2006) (for a revision see (Tikhomirova & Kidd, 2013)). 16S rRNA-based 
microbiome studies have revealed high variability in nasopharyngeal microbial 
communities across individuals and possibly across seasons of the year (Bogaert et 
al., 2011; Laufer et al., 2011). Epidemiological studies have shown a positive 
association between S. pneumoniae and two other pathogenic inhabitants of the 
nasopharynx, Haemophilus influenzae and Moraxella catarrhalis (Jacoby et al., 2007; 
Mackenzie et al., 2010; Pettigrew et al., 2008), although experimental data is not in 
agreement with this observation. A study conducted in a neonatal rat model showed 
that established colonization by S. pneumoniae facilitated colonization by H. influenzae 
(Margolis et al., 2010) but it was also shown in an in vitro study that the hydrogen 
peroxide produced by S. pneumoniae inhibits the growth of H. influenzae and M. 
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catarrhalis (Pericone et al., 2000). Also, Lysenko et al. (Lysenko et al., 2005) showed that 
H. influenzae was dominant in a mouse model through the stimulation of opsonophagocytic 
killing of S. pneumoniae. In addition, there is increasing evidence that bacteria growing 
together in the nasopharynx can alter one another’s gene expression (Cope et al., 
2011) but these mechanisms of interspecies gene regulation remain poorly elucidated. 
The quorum sensing system (QS) LuxS/autoinducer-2 (AI-2) has been shown to 
mediate interspecies communication and has the potential to influence virulence and 
growth, as reviewed in (Pereira et al., 2012). In pneumococci, it was shown that LuxS-
deficient strains are unable to form biofilms at early time points and have impaired DNA 
release ability (Trappetti et al., 2011; Vidal et al., 2011). Moreover, it was also shown 
that the LuxS/AI-2 QS system is involved in the persistence of pneumococci in the 
nasopharynx (Joyce et al., 2004) and in the persistence of H. influenza biofilms in the 
ear cavity (Armbruster et al., 2009). Overall, these data point to the fact that 
intraspecific interactions in the context of a polymicrobial environment might be 
modulated by interactions with other species and should not be disregarded. 
The third question is the role of bacteriophage predation, which has been shown to be 
frequent among pneumococci (Ramirez et al., 1999), on the interaction and co-
existence of pneumococcal strains in the nasopharynx. Phage predation has been 
shown to drive evolution (Weinbauer & Rassoulzadegan, 2004) and to induce genetic 
plasticity that can contribute to the adaptability of pneumococci inside the host. More 
importantly, phages can increase the fitness of the bacterial host, namely by encoding 
virulence factors that contribute to bacterial survival in the mammalian host (Brussow et 
al., 2004). Moreover, Carrolo et al. (Carrolo et al., 2010) have shown that prophage 
spontaneous activation enhances pneumococcal biofilm formation by increasing the 
release of DNA into the extracellular medium and Loeffler et al. (Loeffler & Fischetti, 
2006) have shown that prophage activation increases adherence ability of 
pneumococci to human epithelial cells, both important factors to promote colonization. 
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On the other hand, the large array of phage resistance mechanisms used by bacteria 
indicate that prophage carriage must have an associated fitness cost to the bacteria 
(Labrie et al., 2010). Not many studies have been performed to address this question 
but DeBardeleben et al. (DeBardeleben et al., 2014) have shown that a strain carrying 
a prophage element was outcompeted by its isogenic non-infected sister strain, 
indicating that carriage of that prophage element decreases the fitness of a strain 
during colonization. 
The fourth question is related to the effect of the competition mechanisms explored in 
the context of this thesis on the biofilm structure, as it is generally recognized that this 
lifestyle is important for colonization (Hoa et al., 2009; Kania et al., 2008; Marks et al., 
2012; Psaltis et al., 2007; Sanclement et al., 2005). Carrolo et al. (Carrolo et al., 2014) 
have shown that the presence of CSP in the medium increases the ability of strains to 
form biofilms and that intra-pherotype genetic exchange prevails in these conditions, 
probably due to the spatial organization of the strains in the biofilm. Also, there is 
evidence in the literature that some competition mechanisms are used by bacteria to 
conquer their space within the community, highlighting that positioning within the 
microbial community is important for survival (Kim et al., 2014). Additionally, Oliveira et 
al. (Oliveira et al., 2015) have recently changed the paradigm on the relationship 
between biofilm formation and ecological interactions among bacteria, by proposing 
that biofilm formation is a response to bacterial competition rather than a cooperative 
behavior.  The strategy used in this thesis would not allow us to measure the effect of 
fratricide or bacteriocin secretion at this level, but given that evolution has maintained 
these competition mechanisms, it is possible that their effect might be exerted at a 
smaller scale than the one measured here. 
Finally, but not less important, the fifth question concerns the effect of the host immune 
response on colonization and how it could affect carriage of multiple strains and 
interactions between strains. Brugger et al. (Brugger et al., 2010) showed that 
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colonization density was significantly higher in nasopharyngeal swabs containing 
multiple pneumococcal strains, compared to swabs with a single strain. Also, Margolis 
et al. (Margolis et al., 2010) have shown that sequential colonization with two 
pneumococcal strains results in increased colonization densities to allow the co-
existence of the pulsed and the established strains. Both these studies suggest that 
carriage of multiple strains result in higher carriage densities. The effect of this higher 
density in the host immune response remains to be addressed but could ultimately 
have an impact on pneumococcal carriage. Supporting this hypothesis is the fact the 
immune modulation induced by the presence of other species results in different 
clearance rates of pneumococci (Lysenko et al., 2005). Accordingly, possible changes 
in the immune response induced by carriage of multiple serotypes could have a similar 
effect. Trzciński et al. (Trzcinski et al., 2015) have recently shown in co-infection 
experiments in a mouse model that the innate immunity of naïve mice does not 
influence the relative rankings of serotypes, suggesting no effect on serotype 
interactions in the host. Nevertheless, the same study has shown that, although no 
changes were found in the competitive relationships between serotypes, non-capsular 
immunity induced by previous mice immunization resulted in lower total CFU counts 
recovered from mice, suggesting an indirect effect of acquired immunity on carriage of 
multiple strains. 
The results obtained in the context of this thesis do not allow us to exclude the 
possibility that pneumococci do not compete when in co-colonization. In fact, the 
already mentioned observation of Margolis et al. (Margolis et al., 2010) that sequential 
colonization with two pneumococcal strains resulted in increased colonization densities 
to allow the co-existence of the both strains points towards the idea of co-existence 
rather than competition between pneumococcal strains in the nasopharynx. Moreover, 
if in fact the ecological principles can be transposed to the microbial world, the principle 
that similar competitive abilities facilitate co-existence, proposed by Bengtsson et al. 
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(Bengtsson et al., 1994), supports this hypothesis. On the other hand, the array of 
direct and indirect competition mechanisms maintained by evolution in the 
pneumococcus (Dawid et al., 2007; Guiral et al., 2005; Lux et al., 2007; Nelson et al., 
2007) seem to suggest that competition does occur, which is supported by 
epidemiological and experimental studies (Auranen et al., 2009; Lipsitch et al., 2000). 
Also, studies with other microbial species further support this hypothesis of competition 
rather than cooperation between microbes in the same niche (Foster & Bell, 2012). 
Overall, the studies presented in this thesis give an important contribution to a poorly 
explored field. We showed that co-colonization is a frequent phenomenon and how it 
can be affected by the use of conjugate vaccines and by certain mechanisms intrinsic 
to pneumococcal biology. Still, many interesting questions remain to be answered and 
should be the focus of further research studies. 
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